≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Tibial collateral bursitis [Pellegrini-Stieda]

EFO MESH Endpoint Browser PheWeb

M13_TIBIALCOLLATERAL

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M76.4
  • Hospital discharge: ICD-9 — 7266B|7266C
  • Cause of death: ICD-10 — M76.4
  • Cause of death: ICD-9 — 7266B|7266C

2 out of 7 registries used, show all original rules.

445

4. Check minimum number of events

None

445

5. Include endpoints

None

445

6. Filter based on genotype QC (FinnGen only)

431

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M76
Name in latin
Bursitis anserina

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2376 1534 838
Only index persons 2289 1496 793
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.02
Only index persons 0.05 0.05 0.03
Median age at first event (years)
Whole population 51.13 54.01 45.92
Only index persons 50.96 53.82 45.56

-FinnGen-

Key figures

All Female Male
Number of individuals 431 306 125
Unadjusted period prevalence (%) 0.09 0.11 0.06
Median age at first event (years) 55.32 56.83 51.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
445
Matched controls
4450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.4
ICD-10 Finland
Tibial collateral bursitis [Pellegrini-Stieda]
3459.9
307.7
412
16
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
29.3
115.5
80
33
M48.0
ICD-10 Finland
Spinal stenosis
38.2
112.3
71
22
M54.4
ICD-10 Finland
Lumbago with sciatica
7.4
69.4
120
211
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
17.4
67.8
58
38
M17.1
ICD-10 Finland
Other primary gonarthrosis
5.1
61.3
187
550
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
18.4
51.1
42
25
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
5.5
49.1
116
270
M25.5
ICD-10 Finland
Pain in joint
3.6
39.2
219
940
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.6
39.0
255
1208
M79.6
ICD-10 Finland
Pain in limb
3.6
38.9
271
1336
M54.5
ICD-10 Finland
Low back pain
3.7
37.8
184
720
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
7.7
37.4
56
82
N03AX16
ATC
[U] pregabalin
4.1
36.1
124
381
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
103.7
35.3
38
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.4
33.0
99
274
L15
ICPC
Knee symptom/complaint
3.3
31.8
177
739
M01AH05
ATC
etoricoxib; oral
3.7
31.6
340
2086
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.1
31.2
73
165
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
30.8
80
197
N03AX12
ATC
[U] gabapentin; oral
4.5
29.7
84
221
N02AX02
ATC
tramadol; systemic, rectal
3.0
28.3
214
1051
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.9
27.5
94
284
N06AX21
ATC
duloxetine; oral
4.3
26.8
78
209
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
10.7
26.8
30
30
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.3
26.6
79
215
M76.6
ICD-10 Finland
Achilles tendinitis
6.5
26.6
46
78
N02BF01
ATC
gabapentin; oral
4.7
26.2
66
158
N02AJ06
ATC
codeine and paracetamol; systemic
2.8
25.9
229
1208
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.2
25.6
46
81
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
3.6
25.4
99
326
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.9
24.0
81
241
Z3226
NOMESCO Finland
Physiotherapist
3.3
23.9
111
407
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
132.1
23.8
25
*
M03BC01
ATC
orphenadrine (citrate); systemic
3.1
23.7
124
488
M54.3
ICD-10 Finland
Sciatica
7.8
22.3
32
44
M01AB05
ATC
diclofenac; systemic, rectal
2.9
21.8
329
2205
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.6
20.6
30
42
M70.6
ICD-10 Finland
Trochanteric bursitis
3.3
20.3
89
313
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
30.6
19.9
26
9
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
110.0
19.7
21
*
ZXA05
NOMESCO Finland
Left side
2.7
19.5
137
626
M54.1
ICD-10 Finland
Radiculopathy
16.8
19.1
30
19
M03BX02
ATC
tizanidine; oral
2.6
18.9
304
2033
M02AA07
ATC
piroxicam; topical
2.5
18.6
186
1001
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
18.6
139
652
M54.8
ICD-10 Finland
Other dorsalgia
6.8
18.1
29
45
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
18.0
182
982
7266B
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU BURSITIS REGIONIS LIG GENUS COLL MED]
+∞
17.8
17
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
17.6
144
703
M01AH02
ATC
rofecoxib; oral
3.3
17.6
73
247
M01AH01
ATC
celecoxib; oral
2.9
17.5
98
395
ZXA00
NOMESCO Finland
Right side
2.5
17.0
139
677
7266C
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU BURSITIS REGIONIS LIG GENUS COLL LAT]
+∞
16.8
16
*
Z3231
NOMESCO Finland
Registered nurse
2.5
16.7
143
711
Z50.1
ICD-10 Finland
Other physical therapy
4.7
16.5
40
92
L03
ICPC
Low back symptom/complaint
2.5
16.1
131
635
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
5.5
16.0
32
62
M01AX05
ATC
glucosamine; oral
2.7
16.0
108
478
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.8
15.6
91
373
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.2
15.2
65
223
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
46.7
15.2
18
*
M79.7
ICD-10 Finland
Fibromyalgia
6.4
14.8
25
41
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
14.7
128
636
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
14.7
14
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
14.7
14
*
N02BE01
ATC
paracetamol; systemic, rectal
4.6
14.6
420
3493
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
4.0
14.6
43
115
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
154.9
14.5
15
*
WX320
NOMESCO Finland
Spinalanesthesy
2.4
14.5
134
684
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
14.5
57
186
G44.2
ICD-10 Finland
Tension-type headache
2.9
14.2
77
303
P01AB01
ATC
metronidazole; oral, rectal
2.1
13.8
209
1300
H02AB06
ATC
prednisolone; systemic
2.1
13.8
226
1449
R4110
NOMESCO Finland
Physiotherapy
2.3
13.7
142
758
A01
ICPC
Pain general/multiple sites
3.3
13.7
56
187
M01AX17
ATC
nimesulide; oral
2.4
13.5
118
585
N06AA09
ATC
amitriptyline; systemic
3.4
13.5
51
162
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
13.3
182
1084
A02BC02
ATC
pantoprazole; systemic
2.3
13.2
320
2367
M47.9
ICD-10 Finland
Spondylosis, unspecified
41.4
13.2
16
*
N02BF02
ATC
pregabalin; oral
4.2
13.0
36
92
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
4.0
12.8
38
102
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.5
12.7
32
76
ZB0.1
ICD-10 Finland
Right side
72.0
12.7
14
*
ZXD20
NOMESCO Finland
Day surgery
2.7
12.5
75
310
R51.80
ICD-10 Finland
Headache
2.6
12.5
85
375
R52.2
ICD-10 Finland
Other chronic pain
5.3
12.4
25
49
M01AC06
ATC
meloxicam; systemic, rectal
2.1
12.1
178
1082
R03AC02
ATC
salbutamol; inhalant
2.0
12.0
266
1873
M54.2
ICD-10 Finland
Cervicalgia
3.7
11.8
39
113
M01AE02
ATC
naproxen; oral, rectal
2.0
11.8
264
1859
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
11.7
168
1009
R42
ICD-10 Finland
Dizziness and giddiness
2.2
11.7
118
618
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.5
11.7
41
124
M02AA10
ATC
ketoprofen; topical
2.5
11.6
83
374
1220
FHL
Arthroscopy
4.7
11.6
27
60
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
11.5
99
484
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
11.5
11
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
11.5
334
2578
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
11.4
170
1033
R52.9
ICD-10 Finland
Pain, unspecified
3.0
11.4
55
202
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.1
11.4
52
185
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
11.4
71
299
L01
ICPC
Neck symptom/complaint
2.5
11.4
81
364
XA402
NOMESCO Finland
ENMG
11.6
11.2
20
18
J01AA02
ATC
doxycycline; systemic
2.3
11.1
356
2832
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.5
11.1
40
123
L28
ICPC
Limited function/disability (L)
2.4
11.0
91
437
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
11.0
91
437
L17
ICPC
Foot/toe symptom/complaint
2.1
11.0
151
889
Z2221
NOMESCO Finland
Medical doctor
2.1
10.8
132
742
M54.6
ICD-10 Finland
Pain in thoracic spine
3.7
10.8
35
100
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.8
10.7
57
221
N05CF01
ATC
zopiclone; oral
2.0
10.5
152
910
L02
ICPC
Back symptom/complaint
2.8
10.4
54
206
L16
ICPC
Ankle symptom/complaint
2.6
10.4
67
286
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
10.4
103
533
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.7
10.4
24
53
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.3
120
661
M01AB08
ATC
etodolac; oral
3.2
10.3
42
140
M23.8
ICD-10 Finland
Other internal derangements of knee
4.4
10.2
26
62
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.6
10.1
63
265
A03CA02
ATC
clidinium and psycholeptics; oral
3.7
10.0
32
91
R02
ICPC
Shortness of breath/dyspnoea
2.5
9.9
68
299
M22.4
ICD-10 Finland
Chondromalacia patellae
5.3
9.9
20
39
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.1
9.9
42
143
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
9.8
129
742
S83.2
ICD-10 Finland
Tear of meniscus, current
3.4
9.8
37
117
L86
ICPC
Back syndrome with radiating pain
4.0
9.8
28
73
L12
ICPC
Hand/finger symptom/complaint
2.3
9.8
86
423
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
9.7
141
842
R06AE07
ATC
cetirizine; oral
1.9
9.6
205
1387
NG1AA, ,
SPAT
2.8
9.5
50
192
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
30.7
9.4
12
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
9.4
58
242
R03DC03
ATC
montelukast; oral
2.3
9.3
82
403
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
9.3
69
315
A02BC05
ATC
esomeprazole; systemic
1.9
9.3
184
1214
UJF32
NOMESCO Finland
Coloscopy
2.0
9.3
115
647
M77.1
ICD-10 Finland
Lateral epicondylitis
3.0
9.1
42
150
M01AB55
ATC
diclofenac, combinations; oral
3.4
9.1
33
102
ZXE00
NOMESCO Finland
One hour or less
1.9
9.1
176
1151
M67.4
ICD-10 Finland
Ganglion
3.0
9.0
42
151
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.0
126
739
R05
ICPC
Cough
2.0
9.0
126
739
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
9.0
134
803
M54
ICD-10 Finland
Dorsalgia
2.6
9.0
54
223
L29
ICPC
Musculoskeletal sympt/complt other
2.8
8.9
47
181
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
8.9
130
773
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
8.8
208
1443
Z71.9
ICD-10 Finland
Counselling, unspecified
2.7
8.7
48
189
UKC02
NOMESCO Finland
Cystoscopy
2.4
8.7
64
290
L13
ICPC
Hip symptom/complaint
2.1
8.7
93
494
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
4.9
8.7
19
40
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
8.6
142
878
N01
ICPC
Headache
2.5
8.6
59
259
J01DB01
ATC
cefalexin; oral
2.2
8.5
370
3097
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
6.9
8.5
20
30
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
8.4
39
140
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
8.4
133
811
N06AX11
ATC
mirtazapine; oral
1.9
8.3
157
1012
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.1
8.3
35
119
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
8.3
68
324
WX002
NOMESCO Finland
Sedation and analgesia
2.1
8.3
91
488
X58
ICD-10 Finland
Exposure to other specified factors
2.2
8.2
73
359
H01
ICPC
Ear pain/earache
2.4
8.2
61
278
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
8.2
88
467
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.4
8.1
59
266
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.7
8.1
45
178
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
9.2
8.1
16
18
R05
ICD-10 Finland
Cough
2.0
8.1
109
628
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
8.1
49
203
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
8.1
180
1219
R05FB02
ATC
cough suppressants and expectorants; systemic
1.8
8.1
170
1132
M76.5
ICD-10 Finland
Patellar tendinitis
22.5
8.0
11
5
J45.1
ICD-10 Finland
Nonallergic asthma
3.0
8.0
36
127
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.4
8.0
59
268
R03BA02
ATC
budesonide; inhalant
2.1
8.0
91
494
A29
ICPC
General symptom/complaint other
2.2
8.0
69
336
B01AB05
ATC
enoxaparin; parenteral
1.8
7.9
145
923
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.0
7.9
36
128
H02BX01
ATC
methylprednisolone, combinations; systemic
3.7
7.8
25
71
A02BC03
ATC
lansoprazole; oral
1.9
7.7
124
756
T78.4
ICD-10 Finland
Allergy, unspecified
3.6
7.7
25
72
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
18.7
7.6
11
6
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
7.6
250
1883
S18
ICPC
Laceration/cut
1.7
7.6
204
1452
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
7.5
59
275
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.5
165
1107
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
4.0
7.5
21
54
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.4
7.5
27
83
XLA10, ,
NOMESCO Finland
3.1
7.5
31
104
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.0
7.5
33
115
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
7.5
83
445
NG1AD
NOMESCO Finland
Knee CT examination
7.9
7.4
16
21
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
81.4
7.4
8
*
ZB0.0
ICD-10 Finland
Left side
81.4
7.4
8
*
N02AA05
ATC
oxycodone; systemic
2.1
7.4
75
388
R53
ICD-10 Finland
Malaise and fatigue
1.9
7.4
111
662
N06AB04
ATC
citalopram; systemic
2.0
7.4
94
530
SPAT1058
SPAT
PEF monitoring instruction
2.7
7.3
40
157
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
7.3
7
*
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
16.1
7.3
11
7
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.2
7.2
63
307
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
7.2
34
123
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
20.4
7.2
10
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
7.2
114
692
S29
ICPC
Skin symptom/complaint other
1.9
7.2
98
566
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.7
7.2
38
147
M43.1
ICD-10 Finland
Spondylolisthesis
9.0
7.1
14
16
J02AC01
ATC
fluconazole; systemic
1.7
7.1
186
1308
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
4.0
7.1
20
52
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
7.0
31
108
R4120
NOMESCO Finland
Occupational therapy
2.8
7.0
35
131
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
7.0
319
2607
M79.1
ICD-10 Finland
Myalgia
2.1
7.0
71
368
G43.9
ICD-10 Finland
Migraine, unspecified
3.0
6.9
30
104
M47.82
ICD-10 Finland
Other spondylosis, cervical region
9.5
6.8
13
14
R01AD09
ATC
mometasone; nasal
1.7
6.8
206
1502
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.2
6.7
27
89
D06
ICPC
Abdominal pain localized other
2.5
6.7
44
189
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.7
84
471
J01EA01
ATC
trimethoprim; systemic
1.8
6.6
120
756
G04BD12
ATC
mirabegron; oral
2.2
6.6
61
304
Z71.8
ICD-10 Finland
Other specified counselling
1.7
6.6
154
1043
R21
ICPC
Throat symptom/complaint
1.9
6.6
93
541
R01AD12
ATC
fluticasone furoate; nasal
1.7
6.5
141
935
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
6.5
47
212
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
70.8
6.4
7
*
D11
ICPC
Diarrhoea
2.2
6.4
59
294
K07
ICPC
Swollen ankles/oedema
3.3
6.4
24
76
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
6.7
6.4
15
23
L08
ICPC
Shoulder symptom/complaint
1.8
6.3
102
619
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
2.4
6.3
45
201
G47.3
ICD-10 Finland
Sleep apnoea
1.9
6.3
99
596
B01AB10
ATC
tinzaparin; parenteral
2.2
6.3
54
262
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
6.3
6
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
6.2
110
686
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
5.2
6.2
18
36
M50
ICD-10 Finland
Cervical disc disorders
27.1
6.2
8
*
R03BA01
ATC
beclometasone; inhalant
2.1
6.2
63
326
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.5
6.2
17
32
N04BC05
ATC
pramipexole; oral
2.6
6.2
36
146
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
3.9
6.1
18
48
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
6.1
82
469
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.1
59
300
D01
ICPC
Abdominal pain/cramps general
2.1
6.1
57
286
L78
ICPC
Sprain/strain of knee
6.8
6.1
14
21
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.1
67
358
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.0
6.0
67
359

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Other primary gonarthrosis
M17.1 [45596493]
1.6e+00
2.0e+00
2.5e+00
1.0e+50
3.5e+00
2.9e+00
2.0e+00
cases:10.55%
controls:2.34%
cases:7.34%
controls:1.03%
cases:1.61%
controls:0.14%
cases:10.78%
controls:0.00%
cases:4.37%
controls:0.14%
cases:10.75%
controls:0.66%
cases:17.72%
controls:2.90%
46
102
390
4250
32
45
404
4307
7
6
429
4346
47
0
389
4352
19
6
416
4336
46
28
382
4222
67
108
311
3610
Orthopedic Surgery
20 [38004465]
1.3e+00
1.9e+00
2.6e+00
—
3.5e+00
2.6e+00
1.5e+00
cases:27.29%
controls:9.51%
cases:19.50%
controls:3.61%
cases:6.19%
controls:0.51%
—
—
cases:13.10%
controls:0.46%
cases:31.31%
controls:3.39%
cases:34.39%
controls:10.25%
119
414
317
3938
85
157
351
4195
27
22
409
4330
—
57
20
378
4322
134
144
294
4106
130
381
248
3337
Physical Medicine And Rehabilitation
25 [38004468]
1.7e+00
1.9e+00
2.1e+00
—
2.7e+00
2.7e+00
2.0e+00
cases:14.68%
controls:3.08%
cases:6.65%
controls:1.06%
cases:1.61%
controls:0.21%
—
—
cases:3.22%
controls:0.23%
cases:11.45%
controls:0.87%
cases:16.67%
controls:2.58%
64
134
372
4218
29
46
407
4306
7
9
429
4343
—
14
10
421
4332
49
37
379
4213
63
96
315
3622
Pain in joint
M25.5 [45586941]
1.2e+00
2.2e+00
2.2e+00
—
2.2e+00
1.4e+00
1.4e+00
cases:9.40%
controls:2.92%
cases:9.86%
controls:1.22%
cases:2.06%
controls:0.23%
—
—
cases:1.38%
controls:0.16%
cases:4.91%
controls:1.20%
cases:13.76%
controls:3.68%
41
127
395
4225
43
53
393
4299
9
10
427
4342
—
6
7
429
4335
21
51
407
4199
52
137
326
3581
Outpatient Visit
OP [9202]
6.6e-01
7.5e-01
7.4e-01
5.5e+00
8.4e-01
8.6e-01
1.1e+00
cases:76.83%
controls:63.07%
cases:62.16%
controls:43.57%
cases:17.89%
controls:9.38%
cases:53.44%
controls:0.48%
cases:18.85%
controls:9.10%
cases:63.08%
controls:41.91%
cases:85.71%
controls:67.62%
335
2745
101
1607
271
1896
165
2456
78
408
358
3944
233
21
203
4331
82
395
353
3947
270
1781
158
2469
324
2514
54
1204
gabapentin; oral
N02BF01 [955005]
1.9e+00
1.8e+00
2.8e+00
—
—
2.0e+00
1.7e+00
cases:5.96%
controls:0.90%
cases:3.21%
controls:0.55%
cases:1.83%
controls:0.11%
—
—
—
—
cases:4.44%
controls:0.61%
cases:7.94%
controls:1.48%
26
39
410
4313
14
24
422
4328
8
5
428
4347
—
—
19
26
409
4224
30
55
348
3663
Pain in limb
M79.6 [45587063]
1.4e+00
1.6e+00
1.9e+00
—
2.3e+00
1.0e+00
1.1e+00
cases:13.99%
controls:3.81%
cases:8.49%
controls:1.86%
cases:2.06%
controls:0.30%
—
—
cases:2.07%
controls:0.21%
cases:5.37%
controls:2.02%
cases:15.08%
controls:5.49%
61
166
375
4186
37
81
399
4271
9
13
427
4339
—
9
9
426
4333
23
86
405
4164
57
204
321
3514
Knee symptom/complaint
L15 [2002000639]
1.0e+00
2.5e+00
—
—
2.8e+00
1.5e+00
1.5e+00
cases:5.50%
controls:2.07%
cases:8.26%
controls:0.71%
—
—
—
—
cases:2.30%
controls:0.14%
cases:3.97%
controls:0.87%
cases:12.96%
controls:3.34%
24
90
412
4262
36
31
400
4321
—
—
10
6
425
4336
17
37
411
4213
49
124
329
3594
Partial excision of meniscus of knee, arthroscopic
NGD05 [2001308109]
1.6e+00
2.7e+00
—
—
—
3.4e+00
1.8e+00
cases:2.98%
controls:0.62%
cases:1.61%
controls:0.11%
—
—
—
—
—
—
cases:3.27%
controls:0.12%
cases:2.91%
controls:0.51%
13
27
423
4325
7
5
429
4347
—
—
—
14
5
414
4245
11
19
367
3699
codeine and paracetamol
N02AJ06 [1123647]
9.7e-01
1.3e+00
2.2e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:20.41%
controls:8.85%
cases:10.55%
controls:3.03%
cases:4.59%
controls:0.53%
—
—
cases:2.99%
controls:0.44%
cases:11.92%
controls:2.96%
cases:27.51%
controls:11.19%
89
385
347
3967
46
132
390
4220
20
23
416
4329
—
13
19
422
4323
51
126
377
4124
104
416
274
3302
Extensive examination of musculoskeletal system
SPAT1212 [2001700313]
1.4e+00
2.7e+00
—
—
—
2.5e+00
2.3e+00
cases:2.29%
controls:0.55%
cases:1.61%
controls:0.11%
—
—
—
—
—
—
cases:1.40%
controls:0.12%
cases:4.23%
controls:0.43%
10
24
426
4328
7
5
429
4347
—
—
—
6
5
422
4245
16
16
362
3702
Emergency Room Visit
ER [9203]
7.7e-01
7.3e-01
1.3e+00
4.4e+00
1.1e+00
9.1e-01
5.7e-01
cases:42.66%
controls:25.71%
cases:15.14%
controls:7.88%
cases:3.21%
controls:0.92%
cases:8.94%
controls:0.11%
cases:2.76%
controls:0.92%
cases:17.76%
controls:8.00%
cases:35.45%
controls:23.75%
186
1119
250
3233
66
343
370
4009
14
40
422
4312
39
5
397
4347
12
40
423
4302
76
340
352
3910
134
883
244
2835
Internal derangement of knee, unspecified
M23.9 [45567507]
2.0e+00
2.7e+00
—
1.0e+50
—
2.4e+00
1.4e+00
cases:3.21%
controls:0.46%
cases:2.75%
controls:0.18%
—
—
cases:1.15%
controls:0.00%
—
—
cases:1.87%
controls:0.16%
cases:3.17%
controls:0.78%
14
20
422
4332
12
8
424
4344
—
5
0
431
4352
—
8
7
420
4243
12
29
366
3689
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.3e+00
1.9e+00
2.3e+00
—
2.1e+00
1.6e+00
1.5e+00
cases:11.93%
controls:3.63%
cases:6.42%
controls:1.01%
cases:1.61%
controls:0.16%
—
—
cases:1.15%
controls:0.14%
cases:5.37%
controls:1.13%
cases:14.29%
controls:3.71%
52
158
384
4194
28
44
408
4308
7
7
429
4345
—
5
6
430
4336
23
48
405
4202
54
138
324
3580
Day surgery
ZXD20 [2001311388]
1.5e+00
2.5e+00
—
—
—
2.5e+00
1.5e+00
cases:4.13%
controls:0.92%
cases:2.52%
controls:0.21%
—
—
—
—
—
—
cases:2.57%
controls:0.21%
cases:3.17%
controls:0.70%
18
40
418
4312
11
9
425
4343
—
—
—
11
9
417
4241
12
26
366
3692
General Surgery
2 [38004447]
1.1e+00
1.2e+00
1.5e+00
—
2.0e+00
1.3e+00
9.0e-01
cases:33.03%
controls:14.27%
cases:12.84%
controls:4.27%
cases:2.06%
controls:0.48%
—
—
cases:3.45%
controls:0.48%
cases:12.15%
controls:3.58%
cases:24.60%
controls:11.73%
144
621
292
3731
56
186
380
4166
9
21
427
4331
—
15
21
420
4321
52
152
376
4098
93
436
285
3282
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
1.1e+00
1.1e+00
2.0e+00
1.0e+50
1.7e+00
1.2e+00
6.2e-01
cases:29.59%
controls:11.76%
cases:11.24%
controls:3.98%
cases:3.44%
controls:0.46%
cases:1.38%
controls:0.00%
cases:3.22%
controls:0.60%
cases:11.92%
controls:3.86%
cases:20.11%
controls:11.89%
129
512
307
3840
49
173
387
4179
15
20
421
4332
6
0
430
4352
14
26
421
4316
51
164
377
4086
76
442
302
3276
Gonarthrosis [arthrosis of knee]
M17 [45601350]
1.3e+00
2.3e+00
—
—
—
2.5e+00
1.5e+00
cases:3.44%
controls:0.97%
cases:3.44%
controls:0.37%
—
—
—
—
—
—
cases:3.74%
controls:0.33%
cases:6.61%
controls:1.53%
15
42
421
4310
15
16
421
4336
—
—
—
16
14
412
4236
25
57
353
3661
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
1.5e+00
2.5e+00
—
—
—
1.9e+00
1.3e+00
cases:2.75%
controls:0.60%
cases:1.83%
controls:0.16%
—
—
—
—
—
—
cases:2.34%
controls:0.35%
cases:3.17%
controls:0.86%
12
26
424
4326
8
7
428
4345
—
—
—
10
15
418
4235
12
32
366
3686
Physiotherapist
Z3226 [2001311560]
1.0e+00
1.8e+00
—
—
—
2.3e+00
1.9e+00
cases:4.59%
controls:1.72%
cases:2.52%
controls:0.44%
—
—
—
—
—
—
cases:3.27%
controls:0.33%
cases:6.61%
controls:1.05%
20
75
416
4277
11
19
425
4333
—
—
—
14
14
414
4236
25
39
353
3679
etoricoxib; oral
M01AH05 [21603996]
1.1e+00
1.3e+00
1.1e+00
1.0e+50
2.1e+00
1.4e+00
1.1e+00
cases:26.15%
controls:10.55%
cases:13.53%
controls:4.27%
cases:1.61%
controls:0.55%
cases:3.44%
controls:0.00%
cases:4.60%
controls:0.58%
cases:15.19%
controls:4.05%
cases:28.57%
controls:12.24%
114
459
322
3893
59
186
377
4166
7
24
429
4328
15
0
421
4352
20
25
415
4317
65
172
363
4078
108
455
270
3263
Lumbago with sciatica
M54.4 [45553205]
2.0e+00
1.7e+00
—
—
—
2.4e+00
2.3e+00
cases:4.13%
controls:0.57%
cases:1.15%
controls:0.21%
—
—
—
—
—
—
cases:1.87%
controls:0.16%
cases:7.14%
controls:0.75%
18
25
418
4327
5
9
431
4343
—
—
—
8
7
420
4243
27
28
351
3690
pregabalin; oral
N02BF02 [955152]
1.5e+00
1.7e+00
—
—
1.6e+00
1.9e+00
1.6e+00
cases:8.26%
controls:1.98%
cases:3.90%
controls:0.74%
—
—
—
—
cases:1.15%
controls:0.23%
cases:3.97%
controls:0.59%
cases:9.26%
controls:1.99%
36
86
400
4266
17
32
419
4320
—
—
5
10
430
4332
17
25
411
4225
35
74
343
3644
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
2.1e+00
3.0e+00
—
1.0e+50
1.0e+50
—
1.7e+00
cases:3.67%
controls:0.48%
cases:3.44%
controls:0.18%
—
—
cases:2.52%
controls:0.00%
cases:1.15%
controls:0.00%
—
—
cases:3.17%
controls:0.59%
16
21
420
4331
15
8
421
4344
—
11
0
425
4352
5
0
430
4342
—
12
22
366
3696
Specific gravity of Urine by Test strip
5811-5 [3000330]
1.4e+00
1.9e+00
—
—
—
2.0e+00
1.4e+00
cases:3.21%
controls:0.78%
cases:2.52%
controls:0.39%
—
—
—
—
—
—
cases:3.27%
controls:0.45%
cases:5.82%
controls:1.56%
14
34
422
4318
11
17
425
4335
—
—
—
14
19
414
4231
22
58
356
3660
glucosamine; oral
M01AX05 [21604002]
9.9e-01
1.6e+00
—
—
1.8e+00
1.3e+00
9.6e-01
cases:8.72%
controls:3.42%
cases:5.96%
controls:1.26%
—
—
—
—
cases:1.61%
controls:0.28%
cases:5.37%
controls:1.53%
cases:7.41%
controls:2.96%
38
149
398
4203
26
55
410
4297
—
—
7
12
428
4330
23
65
405
4185
28
110
350
3608
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
7.1e-01
1.0e+00
1.2e+00
—
1.6e+00
8.5e-01
7.0e-01
cases:45.18%
controls:28.86%
cases:28.21%
controls:12.36%
cases:5.05%
controls:1.59%
—
—
cases:8.28%
controls:1.75%
cases:25.47%
controls:12.78%
cases:47.88%
controls:31.41%
197
1256
239
3096
123
538
313
3814
22
69
414
4283
—
36
76
399
4266
109
543
319
3707
181
1168
197
2550
ibuprofen
R02AX02 [1588667]
7.1e-01
1.0e+00
1.2e+00
—
1.6e+00
8.5e-01
7.0e-01
cases:45.18%
controls:28.86%
cases:28.21%
controls:12.36%
cases:5.05%
controls:1.59%
—
—
cases:8.28%
controls:1.75%
cases:25.47%
controls:12.78%
cases:47.88%
controls:31.41%
197
1256
239
3096
123
538
313
3814
22
69
414
4283
—
36
76
399
4266
109
543
319
3707
181
1168
197
2550
Trochanteric bursitis
M70.6 [45606304]
1.3e+00
1.6e+00
—
1.0e+50
—
1.8e+00
1.4e+00
cases:3.67%
controls:1.01%
cases:2.29%
controls:0.48%
—
—
cases:2.52%
controls:0.00%
—
—
cases:2.34%
controls:0.40%
cases:4.76%
controls:1.24%
16
44
420
4308
10
21
426
4331
—
11
0
425
4352
—
10
17
418
4233
18
46
360
3672
Nonallergic asthma
J45.1 [45557625]
1.5e+00
2.4e+00
—
—
—
2.1e+00
1.3e+00
cases:2.75%
controls:0.62%
cases:2.52%
controls:0.23%
—
—
—
—
—
—
cases:1.64%
controls:0.21%
cases:2.38%
controls:0.67%
12
27
424
4325
11
10
425
4342
—
—
—
7
9
421
4241
9
25
369
3693
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.9e+00
1.9e+00
—
—
—
1.6e+00
1.9e+00
cases:2.98%
controls:0.44%
cases:1.83%
controls:0.28%
—
—
—
—
—
—
cases:1.87%
controls:0.40%
cases:6.08%
controls:1.00%
13
19
423
4333
8
12
428
4340
—
—
—
8
17
420
4233
23
37
355
3681
Scheduled procedure
ZXD10 [2001311387]
9.4e-01
1.2e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:12.84%
controls:5.47%
cases:4.36%
controls:1.40%
—
—
cases:1.61%
controls:0.00%
—
—
cases:5.37%
controls:0.68%
cases:13.23%
controls:3.34%
56
238
380
4114
19
61
417
4291
—
7
0
429
4352
—
23
29
405
4221
50
124
328
3594
Headache
R51.80 [2000503603]
1.5e+00
—
—
—
—
2.3e+00
1.9e+00
cases:3.90%
controls:0.92%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.19%
cases:6.35%
controls:1.00%
17
40
419
4312
—
—
—
—
8
8
420
4242
24
37
354
3681
Medical doctor
Z2221 [2001311556]
8.1e-01
1.4e+00
—
—
-1.0e+50
1.8e+00
1.6e+00
cases:6.88%
controls:3.17%
cases:3.44%
controls:0.87%
—
—
—
—
cases:0.00%
controls:0.14%
cases:5.61%
controls:0.96%
cases:12.43%
controls:2.72%
30
138
406
4214
15
38
421
4314
—
—
0
6
435
4336
24
41
404
4209
47
101
331
3617
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.3e+00
1.2e+00
—
—
1.2e+00
1.2e+00
1.7e+00
cases:8.49%
controls:2.46%
cases:3.90%
controls:1.17%
—
—
—
—
cases:1.15%
controls:0.35%
cases:4.91%
controls:1.58%
cases:10.85%
controls:2.26%
37
107
399
4245
17
51
419
4301
—
—
5
15
430
4327
21
67
407
4183
41
84
337
3634
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
8.0e-01
1.2e+00
—
—
2.4e+00
1.1e+00
8.8e-01
cases:6.65%
controls:3.10%
cases:3.67%
controls:1.13%
—
—
—
—
cases:2.07%
controls:0.18%
cases:2.80%
controls:0.92%
cases:7.94%
controls:3.44%
29
135
407
4217
16
49
420
4303
—
—
9
8
426
4334
12
39
416
4211
30
128
348
3590
Gonarthrosis, unspecified
M17.9 [45606128]
9.5e-01
2.4e+00
—
—
—
1.8e+00
1.1e+00
cases:2.98%
controls:1.17%
cases:2.52%
controls:0.23%
—
—
—
—
—
—
cases:3.27%
controls:0.54%
cases:4.23%
controls:1.51%
13
51
423
4301
11
10
425
4342
—
—
—
14
23
414
4227
16
56
362
3662
Rheumatism, unspecified
M79.0 [45567658]
2.8e+00
—
—
—
—
—
2.5e+00
cases:2.52%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.13%
11
7
425
4345
—
—
—
—
—
6
5
372
3713
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
2.8e+00
—
—
—
—
—
2.3e+00
cases:2.29%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.27%
10
6
426
4346
—
—
—
—
—
10
10
368
3708
Case Management Agency
251B00000X [38004193]
1.8e-01
2.7e-01
5.6e-01
3.6e+00
5.4e-01
3.5e-01
2.6e-01
cases:55.73%
controls:51.36%
cases:52.29%
controls:45.66%
cases:28.21%
controls:18.34%
cases:32.80%
controls:1.26%
cases:28.51%
controls:18.89%
cases:57.01%
controls:48.19%
cases:71.69%
controls:66.03%
243
2235
193
2117
228
1987
208
2365
123
798
313
3554
143
55
293
4297
124
820
311
3522
244
2048
184
2202
271
2455
107
1263
Knee X-ray examination without contrast
NG1AA [2001308049]
1.3e+00
—
—
1.0e+50
—
1.7e+00
2.1e+00
cases:3.67%
controls:0.99%
—
—
—
—
cases:2.29%
controls:0.00%
—
—
cases:1.87%
controls:0.35%
cases:6.61%
controls:0.89%
16
43
420
4309
—
—
10
0
426
4352
—
8
15
420
4235
25
33
353
3685
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
6.8e-01
7.1e-01
1.1e+00
—
9.7e-01
6.9e-01
8.6e-01
cases:39.68%
controls:24.91%
cases:23.85%
controls:13.40%
cases:5.96%
controls:2.07%
—
—
cases:5.75%
controls:2.26%
cases:23.60%
controls:13.39%
cases:51.32%
controls:30.85%
173
1084
263
3268
104
583
332
3769
26
90
410
4262
—
25
98
410
4244
101
569
327
3681
194
1147
184
2571
Left side
ZXA05 [2001311347]
7.0e-01
1.3e+00
—
—
—
2.2e+00
1.3e+00
cases:5.73%
controls:2.92%
cases:2.52%
controls:0.71%
—
—
—
—
—
—
cases:3.74%
controls:0.42%
cases:7.41%
controls:2.07%
25
127
411
4225
11
31
425
4321
—
—
—
16
18
412
4232
28
77
350
3641
Pharmacy visit
OMOP4822462 [581458]
6.7e-01
7.8e-01
3.9e-01
2.2e+00
5.7e-01
8.4e-01
7.2e-01
cases:93.81%
controls:88.53%
cases:88.53%
controls:77.90%
cases:48.85%
controls:39.36%
cases:16.28%
controls:2.09%
cases:54.25%
controls:40.03%
cases:89.95%
controls:79.48%
cases:97.09%
controls:94.22%
409
3853
27
499
386
3390
50
962
213
1713
223
2639
71
91
365
4261
236
1738
199
2604
385
3378
43
872
367
3503
11
215
One hour or less
ZXE00 [2001311394]
6.9e-01
1.3e+00
—
1.0e+50
—
1.6e+00
1.2e+00
cases:10.55%
controls:5.58%
cases:4.36%
controls:1.26%
—
—
cases:1.38%
controls:0.00%
—
—
cases:3.97%
controls:0.85%
cases:10.58%
controls:3.34%
46
243
390
4109
19
55
417
4297
—
6
0
430
4352
—
17
36
411
4214
40
124
338
3594
Dyspnoea
R06.0 [45558449]
8.7e-01
1.3e+00
-1.0e+50
—
—
1.6e+00
9.6e-01
cases:5.50%
controls:2.39%
cases:2.75%
controls:0.78%
cases:0.00%
controls:0.14%
—
—
—
—
cases:3.04%
controls:0.61%
cases:7.14%
controls:2.85%
24
104
412
4248
12
34
424
4318
0
6
436
4346
—
—
13
26
415
4224
27
106
351
3612
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
1.3e+00
1.2e+00
—
—
—
1.2e+00
9.7e-01
cases:14.22%
controls:4.34%
cases:4.36%
controls:1.31%
—
—
—
—
—
—
cases:4.21%
controls:1.27%
cases:10.32%
controls:4.17%
62
189
374
4163
19
57
417
4295
—
—
—
18
54
410
4196
39
155
339
3563
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
1.3e+00
1.2e+00
—
—
—
1.2e+00
9.7e-01
cases:14.22%
controls:4.34%
cases:4.36%
controls:1.31%
—
—
—
—
—
—
cases:4.21%
controls:1.27%
cases:10.32%
controls:4.17%
62
189
374
4163
19
57
417
4295
—
—
—
18
54
410
4196
39
155
339
3563
Right side
ZXA00 [2001311346]
9.3e-01
8.6e-01
—
1.0e+50
—
2.5e+00
1.3e+00
cases:7.34%
controls:3.03%
cases:1.83%
controls:0.78%
—
—
cases:1.38%
controls:0.00%
—
—
cases:3.50%
controls:0.31%
cases:7.14%
controls:2.07%
32
132
404
4220
8
34
428
4318
—
6
0
430
4352
—
15
13
413
4237
27
77
351
3641
Knee and lower leg MRI examination with high intensity magnet
NG1BG [2001308056]
2.6e+00
—
—
1.0e+50
—
—
2.0e+00
cases:1.83%
controls:0.14%
—
—
—
—
cases:2.75%
controls:0.00%
—
—
—
—
cases:1.85%
controls:0.24%
8
6
428
4346
—
—
12
0
424
4352
—
—
7
9
371
3709
Primary gonarthrosis, bilateral
M17.0 [45562648]
8.6e-01
1.5e+00
—
1.0e+50
—
1.5e+00
1.5e+00
cases:3.21%
controls:1.38%
cases:3.44%
controls:0.76%
—
—
cases:2.52%
controls:0.00%
—
—
cases:2.34%
controls:0.54%
cases:7.41%
controls:1.83%
14
60
422
4292
15
33
421
4319
—
11
0
425
4352
—
10
23
418
4227
28
68
350
3650
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.7e+00
—
—
—
—
—
2.7e+00
cases:2.52%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.22%
11
20
425
4332
—
—
—
—
—
12
8
366
3710
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
9.9e-01
1.2e+00
—
1.0e+50
2.2e+00
8.9e-01
6.1e-01
cases:9.17%
controls:3.61%
cases:4.36%
controls:1.38%
—
—
cases:1.61%
controls:0.00%
cases:1.61%
controls:0.18%
cases:3.27%
controls:1.36%
cases:6.35%
controls:3.55%
40
157
396
4195
19
60
417
4292
—
7
0
429
4352
7
8
428
4334
14
58
414
4192
24
132
354
3586
tizanidine; oral
M03BX02 [21604116]
1.1e+00
1.0e+00
—
—
—
1.1e+00
1.1e+00
cases:24.54%
controls:9.77%
cases:8.03%
controls:2.96%
—
—
—
—
—
—
cases:9.81%
controls:3.39%
cases:22.49%
controls:9.06%
107
425
329
3927
35
129
401
4223
—
—
—
42
144
386
4106
85
337
293
3381
duloxetine; oral
N06AX21 [21604749]
1.3e+00
1.4e+00
—
—
—
1.2e+00
1.5e+00
cases:2.75%
controls:0.76%
cases:2.29%
controls:0.55%
—
—
—
—
—
—
cases:2.10%
controls:0.64%
cases:3.97%
controls:0.89%
12
33
424
4319
10
24
426
4328
—
—
—
9
27
419
4223
15
33
363
3685
Low back pain
M54.5 [45553207]
1.3e+00
1.3e+00
—
—
—
1.0e+00
1.6e+00
cases:7.57%
controls:2.25%
cases:2.75%
controls:0.76%
—
—
—
—
—
—
cases:2.57%
controls:0.92%
cases:15.34%
controls:3.47%
33
98
403
4254
12
33
424
4319
—
—
—
11
39
417
4211
58
129
320
3589
Ganglion
M67.4 [45582222]
1.1e+00
—
—
—
1.0e+50
2.2e+00
2.0e+00
cases:1.38%
controls:0.46%
—
—
—
—
—
—
cases:1.15%
controls:0.00%
cases:2.10%
controls:0.24%
cases:3.17%
controls:0.46%
6
20
430
4332
—
—
—
5
0
430
4342
9
10
419
4240
12
17
366
3701
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.9e-01
4.8e-01
3.2e-01
2.6e+00
1.9e-01
5.5e-01
5.1e-01
cases:28.44%
controls:22.91%
cases:19.27%
controls:12.91%
cases:3.90%
controls:2.87%
cases:2.52%
controls:0.18%
cases:3.22%
controls:2.67%
cases:21.03%
controls:13.36%
cases:40.74%
controls:29.29%
124
997
312
3355
84
562
352
3790
17
125
419
4227
11
8
425
4344
14
116
421
4226
90
568
338
3682
154
1089
224
2629
Dorsalgia, unspecified
M54.9 [45538791]
2.5e+00
—
—
—
—
1.7e+00
1.7e+00
cases:4.82%
controls:0.41%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.21%
cases:3.44%
controls:0.67%
21
18
415
4334
—
—
—
—
5
9
423
4241
13
25
365
3693
Acromioplastia, arthroscopic
NBG15 [2001307302]
1.7e+00
—
—
—
—
—
2.1e+00
cases:2.06%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.27%
9
16
427
4336
—
—
—
—
—
8
10
370
3708
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
1.0e+00
1.7e+00
—
—
—
1.1e+00
2.8e-01
cases:10.32%
controls:4.02%
cases:5.28%
controls:1.01%
—
—
—
—
—
—
cases:3.97%
controls:1.41%
cases:5.03%
controls:3.85%
45
175
391
4177
23
44
413
4308
—
—
—
17
60
411
4190
19
143
359
3575
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
9.4e-01
1.1e+00
—
—
—
1.7e+00
1.1e+00
cases:3.90%
controls:1.56%
cases:1.83%
controls:0.62%
—
—
—
—
—
—
cases:2.57%
controls:0.49%
cases:4.76%
controls:1.61%
17
68
419
4284
8
27
428
4325
—
—
—
11
21
417
4229
18
60
360
3658
More than one and less than three hours
ZXE10 [2001311401]
6.4e-01
8.8e-01
—
1.0e+50
—
1.5e+00
1.5e+00
cases:8.26%
controls:4.53%
cases:2.52%
controls:1.06%
—
—
cases:1.38%
controls:0.00%
—
—
cases:3.97%
controls:0.89%
cases:11.90%
controls:2.80%
36
197
400
4155
11
46
425
4306
—
6
0
430
4352
—
17
38
411
4212
45
104
333
3614
Primary arthrosis of other joints
M19.0 [45601353]
1.8e+00
1.9e+00
—
—
—
1.3e+00
1.3e+00
cases:2.98%
controls:0.51%
cases:1.83%
controls:0.28%
—
—
—
—
—
—
cases:1.40%
controls:0.38%
cases:2.65%
controls:0.75%
13
22
423
4330
8
12
428
4340
—
—
—
6
16
422
4234
10
28
368
3690
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
9.8e-01
1.6e+00
—
—
—
—
1.1e+00
cases:3.90%
controls:1.49%
cases:2.29%
controls:0.48%
—
—
—
—
—
—
—
—
cases:4.23%
controls:1.43%
17
65
419
4287
10
21
426
4331
—
—
—
—
16
53
362
3665
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
9.6e-01
1.3e+00
—
—
—
1.3e+00
6.9e-01
cases:5.05%
controls:2.00%
cases:2.75%
controls:0.78%
—
—
—
—
—
—
cases:2.80%
controls:0.78%
cases:5.03%
controls:2.58%
22
87
414
4265
12
34
424
4318
—
—
—
12
33
416
4217
19
96
359
3622
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
1.5e+00
—
—
—
—
2.0e+00
1.5e+00
cases:1.38%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.19%
cases:3.44%
controls:0.78%
6
13
430
4339
—
—
—
—
6
8
422
4242
13
29
365
3689
piroxicam; ointment
M02AA07 [21604043]
1.1e+00
1.2e+00
—
—
—
1.2e+00
4.3e-01
cases:8.94%
controls:3.29%
cases:3.90%
controls:1.17%
—
—
—
—
—
—
cases:3.04%
controls:0.96%
cases:4.50%
controls:2.99%
39
143
397
4209
17
51
419
4301
—
—
—
13
41
415
4209
17
111
361
3607
prednisolone
A07EA01 [21600653]
6.8e-01
8.7e-01
—
—
—
9.4e-01
9.5e-01
cases:14.45%
controls:7.88%
cases:7.11%
controls:3.10%
—
—
—
—
—
—
cases:8.64%
controls:3.58%
cases:18.78%
controls:8.18%
63
343
373
4009
31
135
405
4217
—
—
—
37
152
391
4098
71
304
307
3414
prednisolone; oral, parenteral
H02AB06 [21602734]
6.8e-01
8.8e-01
—
—
—
9.1e-01
9.7e-01
cases:14.45%
controls:7.86%
cases:7.11%
controls:3.08%
—
—
—
—
—
—
cases:8.41%
controls:3.55%
cases:18.78%
controls:8.10%
63
342
373
4010
31
134
405
4218
—
—
—
36
151
392
4099
71
301
307
3417
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
9.9e-01
1.2e+00
-1.0e+50
—
—
1.2e+00
4.4e-01
cases:9.40%
controls:3.70%
cases:3.90%
controls:1.19%
cases:0.00%
controls:0.14%
—
—
—
—
cases:3.74%
controls:1.13%
cases:5.03%
controls:3.28%
41
161
395
4191
17
52
419
4300
0
6
436
4346
—
—
16
48
412
4202
19
122
359
3596
Asthma
R96 [2002000961]
8.6e-01
2.1e+00
—
—
—
—
1.3e+00
cases:1.83%
controls:0.78%
cases:1.83%
controls:0.23%
—
—
—
—
—
—
—
—
cases:3.70%
controls:1.05%
8
34
428
4318
8
10
428
4342
—
—
—
—
14
39
364
3679
Acute maxillary sinusitis
J01.0 [45601112]
1.1e+00
9.8e-01
—
—
-1.0e+50
1.4e+00
8.8e-01
cases:5.50%
controls:1.95%
cases:2.06%
controls:0.78%
—
—
—
—
cases:0.00%
controls:0.12%
cases:3.74%
controls:0.96%
cases:7.41%
controls:3.20%
24
85
412
4267
9
34
427
4318
—
—
0
5
435
4337
16
41
412
4209
28
119
350
3599
salbutamol; inhalant
R03AC02 [21603256]
8.7e-01
9.2e-01
1.0e+00
—
2.2e-01
6.6e-01
8.5e-01
cases:22.94%
controls:11.05%
cases:11.47%
controls:4.92%
cases:2.06%
controls:0.76%
—
—
cases:1.15%
controls:0.92%
cases:10.05%
controls:5.46%
cases:25.66%
controls:12.83%
100
481
336
3871
50
214
386
4138
9
33
427
4319
—
5
40
430
4302
43
232
385
4018
97
477
281
3241
pramipexole; oral
N04BC05 [21604477]
1.2e+00
1.8e+00
—
—
1.8e+00
1.5e+00
1.2e+00
cases:2.52%
controls:0.80%
cases:2.75%
controls:0.48%
—
—
—
—
cases:1.38%
controls:0.23%
cases:2.57%
controls:0.56%
cases:2.65%
controls:0.83%
11
35
425
4317
12
21
424
4331
—
—
6
10
429
4332
11
24
417
4226
10
31
368
3687
Ear pain/earache
H01 [2002000475]
4.0e-01
—
—
—
—
2.1e+00
1.2e+00
cases:1.83%
controls:1.24%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.21%
cases:3.70%
controls:1.13%
8
54
428
4298
—
—
—
—
7
9
421
4241
14
42
364
3676
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.4e-01
5.3e-01
8.1e-02
2.3e+00
6.7e-01
4.1e-01
2.5e-01
cases:28.90%
controls:22.52%
cases:25.23%
controls:16.52%
cases:3.90%
controls:3.61%
cases:1.38%
controls:0.14%
cases:5.75%
controls:3.04%
cases:22.66%
controls:16.24%
cases:36.24%
controls:30.63%
126
980
310
3372
110
719
326
3633
17
157
419
4195
6
6
430
4346
25
132
410
4210
97
690
331
3560
137
1139
241
2579
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
1.4e+00
—
—
—
—
1.9e+00
1.3e+00
cases:1.83%
controls:0.46%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.28%
cases:4.76%
controls:1.29%
8
20
428
4332
—
—
—
—
8
12
420
4238
18
48
360
3670
General anesthesia, balanced
WX408 [2001310808]
6.6e-01
1.1e+00
—
—
—
1.8e+00
1.4e+00
cases:5.28%
controls:2.80%
cases:1.61%
controls:0.55%
—
—
—
—
—
—
cases:1.87%
controls:0.33%
cases:6.61%
controls:1.64%
23
122
413
4230
7
24
429
4328
—
—
—
8
14
420
4236
25
61
353
3657
tinzaparin; parenteral
B01AB10 [21600981]
1.4e+00
7.4e-01
—
—
-1.0e+50
—
1.6e+00
cases:2.52%
controls:0.62%
cases:1.15%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.21%
—
—
cases:4.50%
controls:0.91%
11
27
425
4325
5
24
431
4328
—
—
0
9
435
4333
—
17
34
361
3684
naproxen and esomeprazole; oral
M01AE52 [40254096]
9.7e-01
1.3e+00
—
—
—
2.1e+00
4.8e-01
cases:3.67%
controls:1.42%
cases:1.38%
controls:0.37%
—
—
—
—
—
—
cases:2.57%
controls:0.33%
cases:2.38%
controls:1.48%
16
62
420
4290
6
16
430
4336
—
—
—
11
14
417
4236
9
55
369
3663
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
6.3e-01
1.1e+00
—
—
1.4e+00
1.1e+00
7.9e-01
cases:6.88%
controls:3.77%
cases:5.96%
controls:2.02%
—
—
—
—
cases:1.84%
controls:0.46%
cases:6.07%
controls:2.09%
cases:12.70%
controls:6.21%
30
164
406
4188
26
88
410
4264
—
—
8
20
427
4322
26
89
402
4161
48
231
330
3487
Spinalanesthesia
WX320 [2001310799]
7.2e-01
1.2e+00
—
1.0e+50
—
1.5e+00
1.5e+00
cases:5.05%
controls:2.53%
cases:2.52%
controls:0.78%
—
—
cases:1.15%
controls:0.00%
—
—
cases:3.27%
controls:0.73%
cases:10.32%
controls:2.61%
22
110
414
4242
11
34
425
4318
—
5
0
431
4352
—
14
31
414
4219
39
97
339
3621
enoxaparin; parenteral
B01AB05 [21600976]
6.6e-01
5.4e-01
—
—
-1.0e+50
1.2e+00
1.1e+00
cases:7.80%
controls:4.18%
cases:2.06%
controls:1.22%
—
—
—
—
cases:0.00%
controls:0.14%
cases:3.27%
controls:1.06%
cases:9.79%
controls:3.36%
34
182
402
4170
9
53
427
4299
—
—
0
6
435
4336
14
45
414
4205
37
125
341
3593
oxycodone and naloxone; oral
N02AA55 [21604265]
8.1e-01
—
—
—
—
1.4e+00
1.5e+00
cases:2.29%
controls:1.03%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.56%
cases:6.88%
controls:1.69%
10
45
426
4307
—
—
—
—
10
24
418
4226
26
63
352
3655
pantoprazole; oral, parenteral
A02BC02 [21600097]
5.7e-01
8.0e-01
7.2e-01
—
3.1e-01
8.3e-01
6.4e-01
cases:21.79%
controls:13.58%
cases:14.68%
controls:7.19%
cases:3.21%
controls:1.59%
—
—
cases:2.07%
controls:1.52%
cases:15.19%
controls:7.22%
cases:25.13%
controls:15.09%
95
591
341
3761
64
313
372
4039
14
69
422
4283
—
9
66
426
4276
65
307
363
3943
95
561
283
3157
budesonide; inhalant
R03BA02 [21603285]
7.8e-01
9.3e-01
1.2e+00
—
7.8e-01
6.2e-01
1.1e+00
cases:9.40%
controls:4.53%
cases:6.19%
controls:2.53%
cases:1.61%
controls:0.48%
—
—
cases:1.15%
controls:0.53%
cases:4.67%
controls:2.56%
cases:11.38%
controls:4.22%
41
197
395
4155
27
110
409
4242
7
21
429
4331
—
5
23
430
4319
20
109
408
4141
43
157
335
3561
Fibromyalgia
M79.7 [45553272]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.13%
—
—
—
—
—
—
8
5
370
3713
mirabegron; oral
G04BD12 [43534790]
6.8e-01
9.3e-01
—
—
1.1e+00
1.4e+00
1.3e+00
cases:1.83%
controls:0.94%
cases:2.06%
controls:0.83%
—
—
—
—
cases:1.15%
controls:0.37%
cases:3.04%
controls:0.75%
cases:5.82%
controls:1.64%
8
41
428
4311
9
36
427
4316
—
—
5
16
430
4326
13
32
415
4218
22
61
356
3657
Physiotherapy
R4110 [2001310233]
6.2e-01
7.6e-01
—
—
—
1.6e+00
1.2e+00
cases:6.65%
controls:3.70%
cases:2.52%
controls:1.19%
—
—
—
—
—
—
cases:3.27%
controls:0.71%
cases:8.99%
controls:2.99%
29
161
407
4191
11
52
425
4300
—
—
—
14
30
414
4220
34
111
344
3607
pH of Venous blood
2746-6 [3012544]
7.0e-01
1.1e+00
—
—
—
1.5e+00
1.2e+00
cases:2.29%
controls:1.15%
cases:1.38%
controls:0.46%
—
—
—
—
—
—
cases:2.34%
controls:0.52%
cases:6.08%
controls:1.96%
10
50
426
4302
6
20
430
4332
—
—
—
10
22
418
4228
23
73
355
3645
Base excess in Venous blood by calculation
1927-3 [3002032]
7.4e-01
1.2e+00
—
—
—
1.5e+00
1.2e+00
cases:2.29%
controls:1.10%
cases:1.38%
controls:0.44%
—
—
—
—
—
—
cases:2.34%
controls:0.54%
cases:6.35%
controls:2.02%
10
48
426
4304
6
19
430
4333
—
—
—
10
23
418
4227
24
75
354
3643
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
1.1e+00
7.9e-01
—
—
—
1.6e+00
8.5e-01
cases:4.82%
controls:1.70%
cases:1.61%
controls:0.74%
—
—
—
—
—
—
cases:2.57%
controls:0.54%
cases:5.03%
controls:2.21%
21
74
415
4278
7
32
429
4320
—
—
—
11
23
417
4227
19
82
359
3636
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
2.7e+00
—
—
—
—
—
—
cases:1.61%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
429
4347
—
—
—
—
—
—
Palpitations
R00.2 [45558446]
—
—
—
—
—
2.6e+00
5.3e-01
—
—
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.12%
cases:1.32%
controls:0.78%
—
—
—
—
—
7
5
421
4245
5
29
373
3689
Pain/tenderness of skin
S01 [2002000966]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.16%
—
—
—
—
—
—
8
6
370
3712
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
7.7e-01
1.1e+00
—
—
—
1.4e+00
1.1e+00
cases:2.29%
controls:1.08%
cases:1.38%
controls:0.46%
—
—
—
—
—
—
cases:2.34%
controls:0.56%
cases:5.82%
controls:1.99%
10
47
426
4305
6
20
430
4332
—
—
—
10
24
418
4226
22
74
356
3644
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5.2e-01
7.7e-01
6.2e-01
—
1.0e+00
7.6e-01
4.9e-01
cases:12.61%
controls:7.88%
cases:8.49%
controls:4.14%
cases:1.15%
controls:0.62%
—
—
cases:2.07%
controls:0.76%
cases:8.88%
controls:4.38%
cases:18.25%
controls:12.08%
55
343
381
4009
37
180
399
4172
5
27
431
4325
—
9
33
426
4309
38
186
390
4064
69
449
309
3269
trimethoprim; oral, parenteral
J01EA01 [21602931]
8.1e-01
1.1e+00
—
—
—
6.6e-01
6.3e-01
cases:9.40%
controls:4.43%
cases:4.13%
controls:1.47%
—
—
—
—
—
—
cases:4.21%
controls:2.21%
cases:9.79%
controls:5.46%
41
193
395
4159
18
64
418
4288
—
—
—
18
94
410
4156
37
203
341
3515
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
2.5e+00
—
—
—
—
—
—
cases:1.38%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
430
4347
—
—
—
—
—
—
desloratadine; oral
R06AX27 [21603526]
7.5e-01
8.5e-01
—
—
1.2e+00
7.7e-01
8.9e-01
cases:8.26%
controls:4.09%
cases:4.82%
controls:2.11%
—
—
—
—
cases:1.15%
controls:0.35%
cases:4.67%
controls:2.21%
cases:9.79%
controls:4.28%
36
178
400
4174
21
92
415
4260
—
—
5
15
430
4327
20
94
408
4156
37
159
341
3559
Achilles tendinitis
M76.6 [45596682]
2.5e+00
—
—
—
—
—
—
cases:1.61%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
429
4346
—
—
—
—
—
—
Angina pectoris, unspecified
I20.90 [2000502402]
2.5e+00
—
—
—
—
—
—
cases:1.61%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
429
4346
—
—
—
—
—
—
diclofenac
D11AX18 [21602355]
1.1e+00
—
—
—
—
1.3e+00
7.7e-01
cases:5.96%
controls:2.00%
—
—
—
—
—
—
—
—
cases:3.04%
controls:0.82%
cases:3.97%
controls:1.88%
26
87
410
4265
—
—
—
—
13
35
415
4215
15
70
363
3648
diclofenac; ointment
M02AA15 [21604051]
1.1e+00
—
—
—
—
1.3e+00
7.7e-01
cases:5.96%
controls:2.00%
—
—
—
—
—
—
—
—
cases:3.04%
controls:0.82%
cases:3.97%
controls:1.88%
26
87
410
4265
—
—
—
—
13
35
415
4215
15
70
363
3648
Shoulder lesions
M75 [45557983]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.16%
—
—
—
—
—
—
7
6
371
3712
Upper gastrointestinal surgery
106 [44777669]
6.6e-01
4.4e-01
—
—
—
8.6e-01
9.0e-01
cases:11.93%
controls:6.53%
cases:3.67%
controls:2.39%
—
—
—
—
—
—
cases:5.14%
controls:2.24%
cases:16.40%
controls:7.40%
52
284
384
4068
16
104
420
4248
—
—
—
22
95
406
4155
62
275
316
3443
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.1e+00
5.5e-01
—
—
—
8.8e-01
1.4e+00
cases:5.28%
controls:1.91%
cases:1.15%
controls:0.67%
—
—
—
—
—
—
cases:1.40%
controls:0.59%
cases:8.99%
controls:2.45%
23
83
413
4269
5
29
431
4323
—
—
—
6
25
422
4225
34
91
344
3627
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
4.7e-01
6.4e-01
—
—
—
1.3e+00
1.1e+00
cases:5.28%
controls:3.35%
cases:2.06%
controls:1.10%
—
—
—
—
—
—
cases:2.80%
controls:0.75%
cases:8.47%
controls:3.12%
23
146
413
4206
9
48
427
4304
—
—
—
12
32
416
4218
32
116
346
3602
Asthma, unspecified
J45.9 [45562456]
1.1e+00
8.3e-01
—
—
—
1.2e+00
5.8e-01
cases:6.65%
controls:2.27%
cases:2.29%
controls:1.01%
—
—
—
—
—
—
cases:3.04%
controls:0.92%
cases:5.03%
controls:2.88%
29
99
407
4253
10
44
426
4308
—
—
—
13
39
415
4211
19
107
359
3611
Psychiatry
26 [38004469]
1.5e-02
8.2e-01
1.6e+00
—
1.6e+00
8.1e-01
7.0e-01
cases:4.36%
controls:4.30%
cases:4.13%
controls:1.86%
cases:2.06%
controls:0.41%
—
—
cases:1.84%
controls:0.39%
cases:3.74%
controls:1.69%
cases:8.20%
controls:4.25%
19
187
417
4165
18
81
418
4271
9
18
427
4334
—
8
17
427
4325
16
72
412
4178
31
158
347
3560
Cervicalgia
M54.2 [45591867]
2.3e+00
—
—
—
—
—
1.6e+00
cases:2.29%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.38%
10
10
426
4342
—
—
—
—
—
7
14
371
3704
Synovial cyst of popliteal space [Baker]
M71.2 [45596669]
2.3e+00
—
—
—
—
—
—
cases:1.38%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
430
4346
—
—
—
—
—
—
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.2e+00
—
—
—
—
2.3e+00
1.1e+00
cases:2.06%
controls:0.64%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.19%
cases:2.91%
controls:0.94%
9
28
427
4324
—
—
—
—
8
8
420
4242
11
35
367
3683
Ménière disease
H81.0 [45567143]
—
-1.0e+50
—
—
—
—
2.3e+00
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.16%
—
0
5
436
4347
—
—
—
—
6
6
372
3712
Pain in thoracic spine
M54.6 [45606247]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.16%
—
—
—
—
—
—
6
6
372
3712
doxycycline; oral, parenteral
J01AA02 [21602800]
7.9e-01
7.6e-01
—
—
—
5.5e-01
7.1e-01
cases:28.44%
controls:15.30%
cases:8.94%
controls:4.39%
—
—
—
—
—
—
cases:7.71%
controls:4.61%
cases:25.66%
controls:14.52%
124
666
312
3686
39
191
397
4161
—
—
—
33
196
395
4054
97
540
281
3178
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
9.3e-01
1.3e+00
—
—
—
1.0e+00
6.4e-01
cases:4.59%
controls:1.86%
cases:2.52%
controls:0.69%
—
—
—
—
—
—
cases:2.57%
controls:0.94%
cases:3.17%
controls:1.69%
20
81
416
4271
11
30
425
4322
—
—
—
11
40
417
4210
12
63
366
3655
Back syndrome with radiating pain
L86 [2002000705]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.35%
—
—
—
—
—
—
12
13
366
3705
mometasone; nasal
R01AD09 [21605051]
6.7e-01
8.3e-01
—
—
—
5.0e-01
7.3e-01
cases:13.30%
controls:7.31%
cases:6.19%
controls:2.80%
—
—
—
—
—
—
cases:4.44%
controls:2.75%
cases:14.81%
controls:7.75%
58
318
378
4034
27
122
409
4230
—
—
—
19
117
409
4133
56
288
322
3430
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
6.4e-01
8.6e-01
8.7e-01
—
1.0e+00
6.7e-01
7.0e-01
cases:11.93%
controls:6.66%
cases:7.34%
controls:3.24%
cases:1.15%
controls:0.48%
—
—
cases:1.61%
controls:0.58%
cases:6.31%
controls:3.34%
cases:16.40%
controls:8.90%
52
290
384
4062
32
141
404
4211
5
21
431
4331
—
7
25
428
4317
27
142
401
4108
62
331
316
3387
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.24%
—
—
—
—
—
—
8
9
370
3709
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
9.2e-01
—
—
—
—
2.2e+00
1.0e+00
cases:1.38%
controls:0.55%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.19%
cases:2.65%
controls:0.97%
6
24
430
4328
—
—
—
—
7
8
421
4242
10
36
368
3682
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
9.2e-01
—
—
—
—
2.2e+00
1.1e+00
cases:1.38%
controls:0.55%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.19%
cases:2.65%
controls:0.94%
6
24
430
4328
—
—
—
—
7
8
421
4242
10
35
368
3683
Dizziness and giddiness
R42 [45568132]
9.0e-01
—
-1.0e+50
—
—
6.0e-01
1.3e+00
cases:5.05%
controls:2.11%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.40%
controls:0.78%
cases:8.47%
controls:2.53%
22
92
414
4260
—
0
5
436
4347
—
—
6
33
422
4217
32
94
346
3624
Rash and other nonspecific skin eruption
R21 [45553721]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.22%
—
—
—
—
—
—
7
8
371
3710
chondroitin sulfate
M01AX25 [21604013]
1.0e+00
1.2e+00
—
—
—
8.5e-01
1.2e+00
cases:4.36%
controls:1.63%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:1.64%
controls:0.71%
cases:5.03%
controls:1.64%
19
71
417
4281
9
27
427
4325
—
—
—
7
30
421
4220
19
61
359
3657
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
—
2.2e+00
—
—
—
—
9.6e-01
—
—
cases:1.38%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.51%
—
6
7
430
4345
—
—
—
—
5
19
373
3699
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.9e-01
3.4e-01
4.4e-02
2.2e+00
4.7e-01
3.5e-01
2.7e-01
cases:29.36%
controls:25.55%
cases:24.54%
controls:18.75%
cases:3.67%
controls:3.52%
cases:1.38%
controls:0.16%
cases:5.29%
controls:3.36%
cases:24.07%
controls:18.21%
cases:40.74%
controls:34.45%
128
1112
308
3240
107
816
329
3536
16
153
420
4199
6
7
430
4345
23
146
412
4196
103
774
325
3476
154
1281
224
2437
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.0e-01
3.1e-01
1.1e-01
2.2e+00
4.6e-01
3.8e-01
2.7e-01
cases:29.59%
controls:25.69%
cases:24.31%
controls:19.05%
cases:3.90%
controls:3.52%
cases:1.38%
controls:0.16%
cases:5.29%
controls:3.41%
cases:24.77%
controls:18.42%
cases:41.01%
controls:34.70%
129
1118
307
3234
106
829
330
3523
17
153
419
4199
6
7
430
4345
23
148
412
4194
106
783
322
3467
155
1290
223
2428
Result test/procedure
-60 [2002000131]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.19%
—
—
—
—
—
—
6
7
372
3711
General Practice
1 [38004446]
5.7e-01
6.7e-01
9.2e-01
—
7.4e-01
9.4e-01
6.3e-01
cases:13.99%
controls:8.39%
cases:6.19%
controls:3.26%
cases:1.15%
controls:0.46%
—
—
cases:1.15%
controls:0.55%
cases:8.64%
controls:3.58%
cases:17.99%
controls:10.49%
61
365
375
3987
27
142
409
4210
5
20
431
4332
—
5
24
430
4318
37
152
391
4098
68
390
310
3328
Neurology
13 [38004458]
6.4e-01
6.1e-03
6.6e-01
—
—
9.2e-01
5.8e-01
cases:12.84%
controls:7.24%
cases:2.98%
controls:2.96%
cases:1.15%
controls:0.60%
—
—
—
—
cases:6.54%
controls:2.71%
cases:11.90%
controls:7.05%
56
315
380
4037
13
129
423
4223
5
26
431
4326
—
—
28
115
400
4135
45
262
333
3456
Supraglottic ventilation device
WX702 [2001310818]
2.1e+00
—
—
—
—
—
—
cases:2.06%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
9
11
427
4341
—
—
—
—
—
—
fluticasone furoate; nasal
R01AD12 [21605053]
6.3e-01
7.0e-01
—
—
1.1e+00
8.6e-01
6.1e-01
cases:12.39%
controls:6.99%
cases:5.73%
controls:2.92%
—
—
—
—
cases:1.38%
controls:0.48%
cases:7.24%
controls:3.20%
cases:13.49%
controls:7.80%
54
304
382
4048
25
127
411
4225
—
—
6
21
429
4321
31
136
397
4114
51
290
327
3428
fluticasone; nasal
R01AD08 [21605050]
6.3e-01
7.0e-01
—
—
1.1e+00
8.6e-01
6.1e-01
cases:12.39%
controls:6.99%
cases:5.73%
controls:2.92%
—
—
—
—
cases:1.38%
controls:0.48%
cases:7.24%
controls:3.20%
cases:13.49%
controls:7.80%
54
304
382
4048
25
127
411
4225
—
—
6
21
429
4321
31
136
397
4114
51
290
327
3428
Other and unspecified abdominal pain
R10.4 [45568113]
8.8e-01
7.0e-01
-1.0e+50
—
-1.0e+50
9.7e-01
1.2e+00
cases:8.72%
controls:3.79%
cases:2.06%
controls:1.03%
cases:0.00%
controls:0.18%
—
—
cases:0.00%
controls:0.12%
cases:3.27%
controls:1.27%
cases:13.23%
controls:4.33%
38
165
398
4187
9
45
427
4307
0
8
436
4344
—
0
5
435
4337
14
54
414
4196
50
161
328
3557
Rotator cuff syndrome
M75.1 [45596678]
8.5e-01
1.1e+00
—
—
—
7.0e-01
1.2e+00
cases:5.28%
controls:2.32%
cases:2.29%
controls:0.80%
—
—
—
—
—
—
cases:1.87%
controls:0.94%
cases:8.20%
controls:2.53%
23
101
413
4251
10
35
426
4317
—
—
—
8
40
420
4210
31
94
347
3624
Other physical therapy
Z50.1 [45600331]
1.5e+00
—
—
—
—
—
2.1e+00
cases:1.61%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.27%
7
16
429
4336
—
—
—
—
—
8
10
370
3708
Sedation and analgesia
WX002 [2001310758]
1.0e+00
5.8e-01
—
—
—
1.4e+00
1.0e+00
cases:5.73%
controls:2.09%
cases:1.15%
controls:0.64%
—
—
—
—
—
—
cases:1.64%
controls:0.40%
cases:4.23%
controls:1.56%
25
91
411
4261
5
28
431
4324
—
—
—
7
17
421
4233
16
58
362
3660
Outpatient Hospital
22 [8756]
5.2e-01
2.9e-01
—
—
5.1e-01
8.2e-01
7.0e-01
cases:28.90%
controls:19.49%
cases:7.11%
controls:5.42%
—
—
—
—
cases:1.15%
controls:0.69%
cases:9.58%
controls:4.47%
cases:25.93%
controls:14.85%
126
848
310
3504
31
236
405
4116
—
—
5
30
430
4312
41
190
387
4060
98
552
280
3166
Exposure to other specified factors
X58 [45756411]
7.9e-01
1.1e+00
—
—
—
2.0e+00
7.5e-01
cases:2.29%
controls:1.06%
cases:1.15%
controls:0.37%
—
—
—
—
—
—
cases:2.10%
controls:0.28%
cases:2.65%
controls:1.26%
10
46
426
4306
5
16
431
4336
—
—
—
9
12
419
4238
10
47
368
3671
Presence of orthopaedic joint implants
Z96.6 [45600385]
1.5e+00
—
—
—
—
—
2.0e+00
cases:1.15%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.43%
5
11
431
4341
—
—
—
—
—
12
16
366
3702
Abdominal pain localized other
D06 [2002000305]
4.5e-01
—
—
—
—
—
2.0e+00
cases:1.15%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.51%
5
32
431
4320
—
—
—
—
—
14
19
364
3699
Local infiltration anesthesia
WX111 [2001310768]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.30%
—
0
5
436
4347
—
—
—
—
8
11
370
3707
Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]
2.0e+00
—
—
—
—
—
—
cases:1.61%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
429
4342
—
—
—
—
—
—
False labour before 37 completed weeks of gestation
O47.0 [45582556]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.27%
—
—
—
—
—
—
7
10
371
3708
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
4.9e-01
7.1e-01
5.8e-01
—
9.8e-01
7.2e-01
5.2e-01
cases:12.84%
controls:8.27%
cases:8.49%
controls:4.37%
cases:1.15%
controls:0.64%
—
—
cases:2.07%
controls:0.78%
cases:8.64%
controls:4.42%
cases:19.05%
controls:12.32%
56
360
380
3992
37
190
399
4162
5
28
431
4324
—
9
34
426
4308
37
188
391
4062
72
458
306
3260
montelukast; oral
R03DC03 [21603356]
9.1e-01
8.4e-01
—
—
1.3e+00
1.0e+00
7.2e-01
cases:5.50%
controls:2.30%
cases:3.44%
controls:1.52%
—
—
—
—
cases:1.38%
controls:0.37%
cases:4.67%
controls:1.72%
cases:6.08%
controls:3.07%
24
100
412
4252
15
66
421
4286
—
—
6
16
429
4326
20
73
408
4177
23
114
355
3604
Laboratory Visit
OMOP4822461 [32036]
8.2e-02
2.7e-01
1.1e-01
1.9e+00
2.7e-01
2.2e-01
1.2e-01
cases:35.32%
controls:33.48%
cases:36.70%
controls:30.70%
cases:10.55%
controls:9.54%
cases:4.13%
controls:0.62%
cases:11.03%
controls:8.64%
cases:36.68%
controls:31.74%
cases:49.47%
controls:46.42%
154
1457
282
2895
160
1336
276
3016
46
415
390
3937
18
27
418
4325
48
375
387
3967
157
1349
271
2901
187
1726
191
1992
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
5.1e-01
7.3e-01
6.2e-01
—
9.8e-01
7.1e-01
4.9e-01
cases:12.84%
controls:8.16%
cases:8.49%
controls:4.30%
cases:1.15%
controls:0.62%
—
—
cases:2.07%
controls:0.78%
cases:8.64%
controls:4.45%
cases:18.78%
controls:12.37%
56
355
380
3997
37
187
399
4165
5
27
431
4325
—
9
34
426
4308
37
189
391
4061
71
460
307
3258
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
6.3e-01
6.6e-01
—
—
—
7.9e-01
4.9e-01
cases:15.14%
controls:8.64%
cases:7.34%
controls:3.93%
—
—
—
—
—
—
cases:7.24%
controls:3.44%
cases:16.93%
controls:11.05%
66
376
370
3976
32
171
404
4181
—
—
—
31
146
397
4104
64
411
314
3307
Inpatient Hospital
21 [8717]
4.3e-01
2.8e-01
3.1e-01
—
4.7e-01
8.0e-01
6.8e-01
cases:33.49%
controls:24.72%
cases:9.40%
controls:7.28%
cases:1.38%
controls:1.01%
—
—
cases:1.61%
controls:1.01%
cases:13.55%
controls:6.56%
cases:32.54%
controls:19.69%
146
1076
290
3276
41
317
395
4035
6
44
430
4308
—
7
44
428
4298
58
279
370
3971
123
732
255
2986
Observation for suspected nervous system disorder
Z03.3 [45609903]
—
-1.0e+50
—
—
—
-1.0e+50
1.9e+00
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:2.12%
controls:0.32%
—
0
6
436
4346
—
—
—
0
8
428
4242
8
12
370
3706
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
9.0e-01
1.1e+00
-1.0e+50
—
—
5.1e-01
9.9e-01
cases:7.34%
controls:3.13%
cases:1.83%
controls:0.62%
cases:0.00%
controls:0.16%
—
—
—
—
cases:1.17%
controls:0.71%
cases:7.67%
controls:2.99%
32
136
404
4216
8
27
428
4325
0
7
436
4345
—
—
5
30
423
4220
29
111
349
3607
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
8.9e-01
7.0e-01
—
—
—
1.2e+00
1.0e+00
cases:5.05%
controls:2.14%
cases:1.38%
controls:0.69%
—
—
—
—
—
—
cases:2.57%
controls:0.78%
cases:5.03%
controls:1.91%
22
93
414
4259
6
30
430
4322
—
—
—
11
33
417
4217
19
71
359
3647
General symptom/complaint other
A29 [2002000163]
7.8e-01
—
—
—
—
1.9e+00
7.6e-01
cases:2.52%
controls:1.17%
—
—
—
—
—
—
—
—
cases:2.10%
controls:0.33%
cases:3.70%
controls:1.78%
11
51
425
4301
—
—
—
—
9
14
419
4236
14
66
364
3652
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.38%
controls:0.38%
—
—
—
—
—
—
9
14
369
3704
omeprazole; oral, parenteral
A02BC01 [21600096]
8.5e-01
8.0e-01
1.5e+00
—
—
1.0e+00
6.7e-01
cases:5.96%
controls:2.64%
cases:3.21%
controls:1.47%
cases:1.15%
controls:0.25%
—
—
—
—
cases:3.50%
controls:1.32%
cases:5.82%
controls:3.07%
26
115
410
4237
14
64
422
4288
5
11
431
4341
—
—
15
56
413
4194
22
114
356
3604
Coxarthrosis [arthrosis of hip]
M16 [45577162]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.30%
—
—
—
—
—
—
7
11
371
3707
imiquimod
D06BB10 [21602092]
—
-1.0e+50
—
—
—
-1.0e+50
1.8e+00
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:1.85%
controls:0.30%
—
0
6
436
4346
—
—
—
0
8
428
4242
7
11
371
3707
Hand Surgery
40 [38004480]
9.7e-01
1.4e+00
—
—
—
6.6e-01
8.7e-01
cases:5.50%
controls:2.16%
cases:1.61%
controls:0.39%
—
—
—
—
—
—
cases:1.40%
controls:0.73%
cases:5.56%
controls:2.39%
24
94
412
4258
7
17
429
4335
—
—
—
6
31
422
4219
21
89
357
3629
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
—
—
—
—
1.8e+00
7.1e-01
—
—
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.38%
cases:3.44%
controls:1.72%
—
—
—
—
—
10
16
418
4234
13
64
365
3654
Short blood count panel - Blood
55429-5 [40758558]
9.2e-02
6.4e-01
-1.0e+50
—
—
1.1e+00
7.7e-01
cases:4.82%
controls:4.41%
cases:4.13%
controls:2.23%
cases:0.00%
controls:0.39%
—
—
—
—
cases:5.14%
controls:1.84%
cases:10.05%
controls:4.92%
21
192
415
4160
18
97
418
4255
0
17
436
4335
—
—
22
78
406
4172
38
183
340
3535
Pain, unspecified
R52.9 [45544151]
1.8e+00
—
—
—
—
—
8.1e-01
cases:2.52%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.83%
11
18
425
4334
—
—
—
—
—
7
31
371
3687
Chest pain, unspecified
R07.4 [45558450]
8.3e-01
7.0e-01
—
—
—
1.2e+00
9.9e-01
cases:6.42%
controls:2.92%
cases:2.29%
controls:1.15%
—
—
—
—
—
—
cases:2.34%
controls:0.68%
cases:8.73%
controls:3.44%
28
127
408
4225
10
50
426
4302
—
—
—
10
29
418
4221
33
128
345
3590
Gastroenterology
10 [38004455]
7.2e-01
6.9e-01
-1.0e+50
—
-1.0e+50
6.0e-01
1.1e+00
cases:7.11%
controls:3.61%
cases:2.75%
controls:1.40%
cases:0.00%
controls:0.28%
—
—
cases:0.00%
controls:0.18%
cases:2.80%
controls:1.55%
cases:11.11%
controls:4.14%
31
157
405
4195
12
61
424
4291
0
12
436
4340
—
0
8
435
4334
12
66
416
4184
42
154
336
3564
nimesulide; oral
M01AX17 [21604007]
8.9e-01
1.8e+00
—
—
—
-1.0e+50
—
cases:2.75%
controls:1.15%
cases:1.61%
controls:0.28%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
12
50
424
4302
7
12
429
4340
—
—
—
0
14
428
4236
—
citalopram; oral, parenteral
N06AB04 [21604712]
8.5e-01
7.8e-01
—
—
—
8.8e-01
9.2e-01
cases:5.96%
controls:2.64%
cases:2.75%
controls:1.29%
—
—
—
—
—
—
cases:2.57%
controls:1.08%
cases:6.08%
controls:2.53%
26
115
410
4237
12
56
424
4296
—
—
—
11
46
417
4204
23
94
355
3624
cefalexin; oral
J01DB01 [21602870]
4.1e-01
4.7e-01
5.9e-01
—
9.3e-01
7.4e-01
6.1e-01
cases:33.94%
controls:25.41%
cases:10.78%
controls:7.01%
cases:1.61%
controls:0.90%
—
—
cases:2.76%
controls:1.11%
cases:14.25%
controls:7.32%
cases:36.51%
controls:23.88%
148
1106
288
3246
47
305
389
4047
7
39
429
4313
—
12
48
423
4294
61
311
367
3939
138
888
240
2830
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-6.6e-01
—
—
—
1.4e+00
2.8e+00
cases:11.01%
controls:26.82%
cases:4.36%
controls:8.11%
—
—
—
—
—
—
cases:1.64%
controls:0.42%
cases:11.64%
controls:0.78%
48
1167
388
3185
19
353
417
3999
—
—
—
7
18
421
4232
44
29
334
3689
Headache
N01 [2002000720]
8.7e-01
—
—
—
—
1.3e+00
1.7e+00
cases:2.06%
controls:0.87%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.33%
cases:4.23%
controls:0.78%
9
38
427
4314
—
—
—
—
5
14
423
4236
16
29
362
3689
Primary total prosthetic replacement of knee joint without patellar part
NGB20 [2001308094]
6.5e-01
—
—
—
—
1.5e+00
1.7e+00
cases:1.83%
controls:0.97%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.26%
cases:5.56%
controls:1.05%
8
42
428
4310
—
—
—
—
5
11
423
4239
21
39
357
3679
amoxicillin; oral, parenteral
J01CA04 [21602823]
4.6e-01
7.4e-01
—
—
—
4.6e-01
5.0e-01
cases:26.15%
controls:18.34%
cases:10.55%
controls:5.33%
—
—
—
—
—
—
cases:8.88%
controls:5.81%
cases:27.25%
controls:18.48%
114
798
322
3554
46
232
390
4120
—
—
—
38
247
390
4003
103
687
275
3031
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
1.7e+00
—
—
—
—
—
—
cases:2.29%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
—
—
10
19
426
4333
—
—
—
—
—
—
Shoulder X-ray examination without contrast
NB1AA [2001307225]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.40%
—
—
—
—
—
—
8
15
370
3703
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.1e+00
—
—
—
—
—
1.7e+00
cases:1.15%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:2.38%
controls:0.46%
5
17
431
4335
—
—
—
—
—
9
17
369
3701
Cough
R05 [2002000886]
8.4e-01
1.1e+00
-1.0e+50
—
—
7.6e-01
8.3e-01
cases:5.50%
controls:2.46%
cases:1.38%
controls:0.48%
cases:0.00%
controls:0.16%
—
—
—
—
cases:1.40%
controls:0.66%
cases:6.88%
controls:3.12%
24
107
412
4245
6
21
430
4331
0
7
436
4345
—
—
6
28
422
4222
26
116
352
3602
Foot/toe symptom/complaint
L17 [2002000641]
8.4e-01
5.2e-01
—
—
—
6.5e-01
8.2e-01
cases:5.73%
controls:2.55%
cases:1.83%
controls:1.10%
—
—
—
—
—
—
cases:2.10%
controls:1.11%
cases:8.73%
controls:4.03%
25
111
411
4241
8
48
428
4304
—
—
—
9
47
419
4203
33
150
345
3568
Otolaryngology
4 [38004449]
7.1e-01
5.9e-01
—
—
—
3.6e-01
9.2e-01
cases:16.74%
controls:8.98%
cases:5.73%
controls:3.26%
—
—
—
—
—
—
cases:4.91%
controls:3.46%
cases:20.11%
controls:9.12%
73
391
363
3961
25
142
411
4210
—
—
—
21
147
407
4103
76
339
302
3379
Back symptom/complaint
L02 [2002000627]
1.4e+00
-1.0e+50
—
—
—
—
1.6e+00
cases:1.83%
controls:0.44%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
cases:4.50%
controls:0.91%
8
19
428
4333
0
10
436
4342
—
—
—
—
17
34
361
3684
Neurosurgery
14 [38004459]
7.8e-01
—
—
—
—
—
1.6e+00
cases:2.52%
controls:1.17%
—
—
—
—
—
—
—
—
—
—
cases:4.23%
controls:0.86%
11
51
425
4301
—
—
—
—
—
16
32
362
3686
Obesity
E66 [45547648]
1.6e+00
-1.0e+50
—
—
—
—
7.2e-01
cases:1.83%
controls:0.37%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.65%
8
16
428
4336
0
5
436
4347
—
—
—
—
5
24
373
3694
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]
1.6e+00
—
—
—
—
—
—
cases:1.83%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
428
4336
—
—
—
—
—
—
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
1.5e+00
—
—
—
—
2.0e+00
1.6e+00
cases:1.38%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.16%
cases:3.44%
controls:0.70%
6
13
430
4339
—
—
—
—
5
7
423
4243
13
26
365
3692
EKG study
11524-6 [3013512]
4.5e-01
9.1e-01
—
—
—
6.8e-01
7.0e-01
cases:8.26%
controls:5.42%
cases:6.42%
controls:2.69%
—
—
—
—
—
—
cases:5.37%
controls:2.80%
cases:12.17%
controls:6.43%
36
236
400
4116
28
117
408
4235
—
—
—
23
119
405
4131
46
239
332
3479
naproxcinod
M01AE18 [40254094]
5.0e-01
9.5e-01
—
—
—
6.3e-01
6.5e-01
cases:13.30%
controls:8.55%
cases:6.42%
controls:2.60%
—
—
—
—
—
—
cases:4.91%
controls:2.68%
cases:13.49%
controls:7.50%
58
372
378
3980
28
113
408
4239
—
—
—
21
114
407
4136
51
279
327
3439
naproxen; oral, rectal
M01AE02 [21603968]
5.0e-01
9.5e-01
—
—
—
6.3e-01
6.5e-01
cases:13.30%
controls:8.55%
cases:6.42%
controls:2.60%
—
—
—
—
—
—
cases:4.91%
controls:2.68%
cases:13.49%
controls:7.50%
58
372
378
3980
28
113
408
4239
—
—
—
21
114
407
4136
51
279
327
3439
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
5.1e-01
8.9e-01
—
—
1.1e+00
5.8e-01
7.1e-01
cases:7.57%
controls:4.66%
cases:5.05%
controls:2.14%
—
—
—
—
cases:1.15%
controls:0.37%
cases:4.21%
controls:2.40%
cases:11.11%
controls:5.81%
33
203
403
4149
22
93
414
4259
—
—
5
16
430
4326
18
102
410
4148
42
216
336
3502
epinephrine; parenteral
C01CA24 [21600303]
1.6e+00
2.0e+00
—
—
—
—
8.7e-01
cases:2.29%
controls:0.48%
cases:1.15%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.67%
10
21
426
4331
5
7
431
4345
—
—
—
—
6
25
372
3693
epinephrine
S01EA01 [21603673]
1.6e+00
2.0e+00
—
—
—
—
8.7e-01
cases:2.29%
controls:0.48%
cases:1.15%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.67%
10
21
426
4331
5
7
431
4345
—
—
—
—
6
25
372
3693
Tension-type headache
G44.2 [45581495]
1.1e+00
—
—
—
—
—
1.6e+00
cases:2.06%
controls:0.71%
—
—
—
—
—
—
—
—
—
—
cases:4.50%
controls:0.97%
9
31
427
4321
—
—
—
—
—
17
36
361
3682
betahistine; oral
N07CA01 [21604833]
1.3e+00
—
—
—
—
—
1.6e+00
cases:1.61%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.56%
7
20
429
4332
—
—
—
—
—
10
21
368
3697
esomeprazole; oral, parenteral
A02BC05 [21600100]
7.8e-01
5.5e-01
8.7e-01
—
—
6.4e-01
7.5e-01
cases:13.30%
controls:6.55%
cases:5.73%
controls:3.38%
cases:1.15%
controls:0.48%
—
—
—
—
cases:5.61%
controls:3.04%
cases:13.23%
controls:6.72%
58
285
378
4067
25
147
411
4205
5
21
431
4331
—
—
24
129
404
4121
50
250
328
3468
rofecoxib; oral
M01AH02 [21603993]
1.5e+00
—
—
—
—
—
—
cases:3.21%
controls:0.71%
—
—
—
—
—
—
—
—
—
—
—
—
14
31
422
4321
—
—
—
—
—
—
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.0e-01
3.3e-01
—
—
—
8.3e-01
6.7e-01
cases:8.03%
controls:5.51%
cases:3.44%
controls:2.50%
—
—
—
—
—
—
cases:5.14%
controls:2.31%
cases:11.64%
controls:6.29%
35
240
401
4112
15
109
421
4243
—
—
—
22
98
406
4152
44
234
334
3484
Infiltration anesthesia
WX110 [2001310767]
4.3e-01
4.4e-01
6.2e-01
—
9.6e-01
6.3e-01
4.5e-01
cases:20.41%
controls:14.29%
cases:8.94%
controls:5.95%
cases:1.15%
controls:0.62%
—
—
cases:1.61%
controls:0.62%
cases:8.88%
controls:4.94%
cases:23.81%
controls:16.68%
89
622
347
3730
39
259
397
4093
5
27
431
4325
—
7
27
428
4315
38
210
390
4040
90
620
288
3098
Bacteria identified in Stool by Culture
625-4 [3025941]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.91%
controls:0.67%
—
—
—
—
—
—
11
25
367
3693
candesartan; oral
C09CA06 [21601829]
7.8e-01
7.0e-01
8.0e-01
—
4.8e-01
6.5e-01
4.5e-01
cases:8.49%
controls:4.07%
cases:7.34%
controls:3.79%
cases:2.06%
controls:0.94%
—
—
cases:2.07%
controls:1.29%
cases:7.48%
controls:4.05%
cases:8.47%
controls:5.57%
37
177
399
4175
32
165
404
4187
9
41
427
4311
—
9
56
426
4286
32
172
396
4078
32
207
346
3511
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
4.2e-01
4.1e-01
4.6e-01
—
6.6e-01
5.2e-01
5.4e-01
cases:26.61%
controls:19.26%
cases:20.18%
controls:14.36%
cases:5.05%
controls:3.24%
—
—
cases:6.90%
controls:3.68%
cases:21.73%
controls:14.14%
cases:30.16%
controls:20.12%
116
838
320
3514
88
625
348
3727
22
141
414
4211
—
30
160
405
4182
93
601
335
3649
114
748
264
2970
zopiclone; oral
N05CF01 [21604654]
5.1e-01
4.8e-01
5.1e-01
—
9.5e-01
7.5e-01
7.2e-01
cases:9.63%
controls:6.04%
cases:5.28%
controls:3.33%
cases:1.38%
controls:0.83%
—
—
cases:2.30%
controls:0.90%
cases:7.01%
controls:3.44%
cases:12.17%
controls:6.29%
42
263
394
4089
23
145
413
4207
6
36
430
4316
—
10
39
425
4303
30
146
398
4104
46
234
332
3484
FEV1 percent change
69983-5 [42868472]
6.7e-01
1.5e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:1.31%
cases:1.83%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
11
57
425
4295
8
18
428
4334
—
—
—
—
10
23
368
3695
Chest pain NOS
A11 [2002000152]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
—
—
—
—
—
—
10
23
368
3695
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
6.7e-01
1.5e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:1.31%
cases:1.83%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
11
57
425
4295
8
18
428
4334
—
—
—
—
10
23
368
3695
FEV1/FVC --post bronchodilation
69970-2 [42868459]
6.7e-01
1.5e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:1.31%
cases:1.83%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
11
57
425
4295
8
18
428
4334
—
—
—
—
10
23
368
3695
FEV1 --post bronchodilation
20155-8 [3023550]
6.7e-01
1.5e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:1.31%
cases:1.83%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
11
57
425
4295
8
18
428
4334
—
—
—
—
10
23
368
3695
FVC percent change Respiratory system
69982-7 [42868471]
6.7e-01
1.5e+00
—
—
—
—
1.5e+00
cases:2.52%
controls:1.31%
cases:1.83%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.62%
11
57
425
4295
8
18
428
4334
—
—
—
—
10
23
368
3695
Exposure to unspecified factor
X59 [45756412]
6.1e-01
1.5e+00
—
—
—
1.1e+00
9.8e-01
cases:2.75%
controls:1.52%
cases:2.06%
controls:0.48%
—
—
—
—
—
—
cases:1.40%
controls:0.47%
cases:3.70%
controls:1.43%
12
66
424
4286
9
21
427
4331
—
—
—
6
20
422
4230
14
53
364
3665
Dorsalgia
M54 [45553203]
7.0e-01
—
—
—
—
1.5e+00
1.5e+00
cases:1.15%
controls:0.57%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.33%
cases:3.17%
controls:0.75%
5
25
431
4327
—
—
—
—
6
14
422
4236
12
28
366
3690
Pain general/multiple sites
A01 [2002000142]
—
—
—
—
—
1.6e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.24%
cases:3.97%
controls:0.97%
—
—
—
—
—
5
10
423
4240
15
36
363
3682
azithromycin; oral, parenteral
J01FA10 [21602978]
7.7e-01
7.1e-01
—
—
—
6.5e-01
6.5e-01
cases:15.60%
controls:7.86%
cases:3.44%
controls:1.72%
—
—
—
—
—
—
cases:3.97%
controls:2.12%
cases:12.17%
controls:6.75%
68
342
368
4010
15
75
421
4277
—
—
—
17
90
411
4160
46
251
332
3467
Spirometry at the office
SPAT1059 [2001700160]
1.4e+00
—
—
—
—
—
—
cases:2.29%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
—
10
25
426
4327
—
—
—
—
—
—
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.4e+00
—
—
—
—
—
4.3e-01
cases:2.98%
controls:0.76%
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.86%
13
33
423
4319
—
—
—
—
—
5
32
373
3686
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
9.8e-01
—
—
—
—
—
1.4e+00
cases:2.06%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.67%
9
34
427
4318
—
—
—
—
—
10
25
368
3693
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
1.4e+00
—
—
—
—
—
6.9e-01
cases:3.21%
controls:0.83%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.94%
14
36
422
4316
—
—
—
—
—
7
35
371
3683
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
1.2e+00
—
—
—
-1.0e+50
1.7e+00
1.4e+00
cases:1.83%
controls:0.55%
—
—
—
—
—
—
cases:0.00%
controls:0.12%
cases:1.64%
controls:0.31%
cases:4.23%
controls:1.10%
8
24
428
4328
—
—
—
0
5
435
4337
7
13
421
4237
16
41
362
3677
Vertigo/dizziness
N17 [2002000728]
8.4e-01
—
—
—
—
—
1.4e+00
cases:2.52%
controls:1.10%
—
—
—
—
—
—
—
—
—
—
cases:4.23%
controls:1.10%
11
48
425
4304
—
—
—
—
—
16
41
362
3677
Plantar fascial fibromatosis
M72.2 [45553265]
1.1e+00
—
—
—
—
1.5e+00
1.4e+00
cases:1.38%
controls:0.46%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.26%
cases:2.91%
controls:0.75%
6
20
430
4332
—
—
—
—
5
11
423
4239
11
28
367
3690
Pulmonary Disease
29 [38004472]
3.0e-01
4.3e-01
5.8e-01
—
1.2e+00
7.4e-01
6.1e-01
cases:8.72%
controls:6.62%
cases:5.05%
controls:3.33%
cases:1.15%
controls:0.64%
—
—
cases:2.07%
controls:0.64%
cases:6.78%
controls:3.34%
cases:12.17%
controls:7.02%
38
288
398
4064
22
145
414
4207
5
28
431
4324
—
9
28
426
4314
29
142
399
4108
46
261
332
3457
After-cataract
H26.4 [45600893]
1.3e+00
—
—
—
—
-1.0e+50
—
cases:2.52%
controls:0.67%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.38%
—
—
11
29
425
4323
—
—
—
—
0
16
428
4234
—
Internal Medicine
11 [38004456]
6.2e-01
5.1e-01
5.4e-01
—
—
3.7e-01
7.2e-01
cases:27.75%
controls:17.12%
cases:10.32%
controls:6.48%
cases:2.29%
controls:1.36%
—
—
—
—
cases:9.58%
controls:6.82%
cases:26.98%
controls:15.28%
121
745
315
3607
45
282
391
4070
10
59
426
4293
—
—
41
290
387
3960
102
568
276
3150
FEV1
20150-9 [3024653]
5.2e-01
1.3e+00
—
—
—
—
1.3e+00
cases:2.52%
controls:1.52%
cases:1.83%
controls:0.53%
—
—
—
—
—
—
—
—
cases:2.91%
controls:0.78%
11
66
425
4286
8
23
428
4329
—
—
—
—
11
29
367
3689
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
5.2e-01
1.3e+00
—
—
—
—
1.3e+00
cases:2.52%
controls:1.52%
cases:1.83%
controls:0.53%
—
—
—
—
—
—
—
—
cases:2.91%
controls:0.78%
11
66
425
4286
8
23
428
4329
—
—
—
—
11
29
367
3689
FEV1/FVC
19926-5 [3011505]
5.2e-01
1.3e+00
—
—
—
—
1.3e+00
cases:2.52%
controls:1.52%
cases:1.83%
controls:0.53%
—
—
—
—
—
—
—
—
cases:2.91%
controls:0.78%
11
66
425
4286
8
23
428
4329
—
—
—
—
11
29
367
3689
Cervicobrachial syndrome
M53.1 [45567577]
9.6e-01
—
—
—
—
—
1.3e+00
cases:2.06%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.86%
9
35
427
4317
—
—
—
—
—
12
32
366
3686
Emergency Medicine
93 [38004510]
4.4e-01
6.6e-01
1.1e+00
—
6.7e-01
6.7e-01
3.5e-01
cases:14.45%
controls:9.79%
cases:8.26%
controls:4.46%
cases:2.06%
controls:0.71%
—
—
cases:1.38%
controls:0.71%
cases:9.58%
controls:5.15%
cases:19.58%
controls:14.60%
63
426
373
3926
36
194
400
4158
9
31
427
4321
—
6
31
429
4311
41
219
387
4031
74
543
304
3175
Ankle symptom/complaint
L16 [2002000640]
1.1e+00
-1.0e+50
—
—
—
—
1.3e+00
cases:2.06%
controls:0.67%
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:3.44%
controls:0.94%
9
29
427
4323
0
7
436
4345
—
—
—
—
13
35
365
3683
Sprain and strain of ankle
S93.4 [45550848]
1.3e+00
-1.0e+50
—
—
—
—
9.1e-01
cases:2.75%
controls:0.76%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.86%
12
33
424
4319
0
13
436
4339
—
—
—
—
8
32
370
3686
oxycodone; oral, parenteral
N02AA05 [21604260]
1.3e+00
1.1e+00
—
—
—
1.3e+00
9.8e-01
cases:2.52%
controls:0.71%
cases:1.15%
controls:0.37%
—
—
—
—
—
—
cases:1.87%
controls:0.49%
cases:3.97%
controls:1.53%
11
31
425
4321
5
16
431
4336
—
—
—
8
21
420
4229
15
57
363
3661
Intravenous general anesthesia
WX404 [2001310807]
7.9e-01
1.1e+00
—
—
—
1.5e+00
1.3e+00
cases:4.82%
controls:2.25%
cases:1.61%
controls:0.53%
—
—
—
—
—
—
cases:1.40%
controls:0.33%
cases:4.50%
controls:1.29%
21
98
415
4254
7
23
429
4329
—
—
—
6
14
422
4236
17
48
361
3670
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
1.1e+00
—
—
—
—
1.5e+00
1.3e+00
cases:2.06%
controls:0.71%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.35%
cases:4.76%
controls:1.37%
9
31
427
4321
—
—
—
—
7
15
421
4235
18
51
360
3667
Examination and observation for other specified reasons
Z04.8 [45552063]
1.3e+00
—
—
—
—
—
9.8e-01
cases:2.75%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:3.44%
controls:1.32%
12
34
424
4318
—
—
—
—
—
13
49
365
3669
Obesity due to excess calories
E66.01 [2000501501]
1.3e+00
7.0e-01
-1.0e+50
—
—
—
1.2e+00
cases:2.29%
controls:0.67%
cases:1.15%
controls:0.57%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:3.44%
controls:1.02%
10
29
426
4323
5
25
431
4327
0
6
436
4346
—
—
—
13
38
365
3680
Other specified urinary incontinence
N39.4 [45577525]
3.3e-01
8.8e-01
—
—
—
1.5e+00
1.2e+00
cases:1.15%
controls:0.83%
cases:1.38%
controls:0.57%
—
—
—
—
—
—
cases:1.40%
controls:0.31%
cases:3.44%
controls:1.02%
5
36
431
4316
6
25
430
4327
—
—
—
6
13
422
4237
13
38
365
3680
Pain localized to upper abdomen
R10.1 [45568111]
2.8e-01
—
—
—
—
1.4e+00
1.2e+00
cases:2.06%
controls:1.56%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.42%
cases:5.29%
controls:1.61%
9
68
427
4284
—
—
—
—
7
18
421
4232
20
60
358
3658
ketoprofen; ointment
M02AA10 [21604046]
1.2e+00
1.2e+00
—
1.0e+50
—
—
1.0e+00
cases:3.21%
controls:0.97%
cases:1.61%
controls:0.51%
—
—
cases:1.38%
controls:0.00%
—
—
—
—
cases:3.44%
controls:1.29%
14
42
422
4310
7
22
429
4330
—
6
0
430
4352
—
—
13
48
365
3670
celecoxib
L01XX33 [21603805]
1.2e+00
1.0e+00
—
—
—
—
6.2e-01
cases:4.59%
controls:1.40%
cases:1.15%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.38%
controls:1.29%
20
61
416
4291
5
18
431
4334
—
—
—
—
9
48
369
3670
celecoxib; oral
M01AH01 [21603992]
1.2e+00
1.0e+00
—
—
—
—
6.2e-01
cases:4.59%
controls:1.40%
cases:1.15%
controls:0.41%
—
—
—
—
—
—
—
—
cases:2.38%
controls:1.29%
20
61
416
4291
5
18
431
4334
—
—
—
—
9
48
369
3670
Abdominal pain/cramps general
D01 [2002000300]
5.8e-01
—
—
—
—
—
1.2e+00
cases:1.83%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:4.23%
controls:1.29%
8
45
428
4307
—
—
—
—
—
16
48
362
3670
pseudoephedrine, combinations; oral
R01BA52 [21603213]
5.4e-01
5.3e-01
-1.0e+50
—
-1.0e+50
4.8e-01
6.6e-01
cases:13.99%
controls:8.69%
cases:4.59%
controls:2.76%
cases:0.00%
controls:0.21%
—
—
cases:0.00%
controls:0.48%
cases:4.44%
controls:2.80%
cases:15.34%
controls:8.58%
61
378
375
3974
20
120
416
4232
0
9
436
4343
—
0
21
435
4321
19
119
409
4131
58
319
320
3399
Acute upper respiratory infection, unspecified
J06.9 [45562437]
6.6e-01
1.9e-01
—
—
—
4.1e-01
5.3e-01
cases:10.09%
controls:5.47%
cases:2.98%
controls:2.48%
—
—
—
—
—
—
cases:4.67%
controls:3.15%
cases:14.29%
controls:8.93%
44
238
392
4114
13
108
423
4244
—
—
—
20
134
408
4116
54
332
324
3386
Cough
R05 [45606792]
1.2e+00
8.4e-01
-1.0e+50
—
—
—
1.3e-01
cases:5.96%
controls:1.93%
cases:1.38%
controls:0.60%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:3.17%
controls:2.80%
26
84
410
4268
6
26
430
4326
0
5
436
4347
—
—
—
12
104
366
3614
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.0e+00
—
—
—
—
1.6e+00
1.2e+00
cases:2.29%
controls:0.83%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.40%
cases:5.56%
controls:1.80%
10
36
426
4316
—
—
—
—
8
17
420
4233
21
67
357
3651
Skin symptom/complaint other
S29 [2002000993]
4.3e-01
—
—
—
—
—
1.2e+00
cases:2.75%
controls:1.82%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:1.80%
12
79
424
4273
—
—
—
—
—
21
67
357
3651
hydroxyzine; oral, parenteral
N05BB01 [21604590]
7.5e-01
—
—
—
—
—
1.2e+00
cases:2.98%
controls:1.42%
—
—
—
—
—
—
—
—
—
—
cases:4.23%
controls:1.37%
13
62
423
4290
—
—
—
—
—
16
51
362
3667
semaglutide; oral, parenteral
A10BJ06 [1501778]
1.3e+00
7.0e-01
—
—
—
8.2e-01
1.2e+00
cases:1.38%
controls:0.39%
cases:1.38%
controls:0.69%
—
—
—
—
—
—
cases:2.10%
controls:0.94%
cases:5.03%
controls:1.64%
6
17
430
4335
6
30
430
4322
—
—
—
9
40
419
4210
19
61
359
3657
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
8.4e-01
1.6e+00
—
—
-1.0e+50
—
1.1e+00
cases:1.38%
controls:0.60%
cases:1.61%
controls:0.34%
—
—
—
—
cases:0.00%
controls:0.12%
—
—
cases:4.50%
controls:1.48%
6
26
430
4326
7
15
429
4337
—
—
0
5
435
4337
—
17
55
361
3663
phenoxymethylpenicillin; oral
J01CE02 [21602842]
5.0e-01
-2.0e-01
—
—
—
1.2e-01
6.4e-01
cases:17.89%
controls:11.67%
cases:2.75%
controls:3.33%
—
—
—
—
—
—
cases:4.21%
controls:3.76%
cases:20.11%
controls:11.70%
78
508
358
3844
12
145
424
4207
—
—
—
18
160
410
4090
76
435
302
3283
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
5.0e-01
-2.0e-01
—
—
—
1.2e-01
6.4e-01
cases:17.89%
controls:11.67%
cases:2.75%
controls:3.33%
—
—
—
—
—
—
cases:4.21%
controls:3.76%
cases:20.11%
controls:11.70%
78
508
358
3844
12
145
424
4207
—
—
—
18
160
410
4090
76
435
302
3283
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.44%
controls:1.16%
—
—
—
—
—
—
13
43
365
3675
Obstetrics / Gynecology
16 [38004461]
4.2e-01
4.5e-01
8.8e-01
—
—
6.3e-01
4.7e-01
cases:20.64%
controls:14.64%
cases:9.40%
controls:6.23%
cases:2.52%
controls:1.06%
—
—
—
—
cases:9.11%
controls:5.06%
cases:19.58%
controls:13.18%
90
637
346
3715
41
271
395
4081
11
46
425
4306
—
—
39
215
389
4035
74
490
304
3228
Bacteria identified in Urine by Culture
630-4 [3026008]
4.5e-01
1.1e+00
—
—
—
7.6e-01
5.9e-01
cases:6.88%
controls:4.48%
cases:5.28%
controls:1.82%
—
—
—
—
—
—
cases:4.67%
controls:2.24%
cases:10.85%
controls:6.29%
30
195
406
4157
23
79
413
4273
—
—
—
20
95
408
4155
41
234
337
3484
Telehealth
OMOP5556618 [722455]
2.3e-01
3.2e-01
—
—
2.2e-01
6.4e-01
4.5e-01
cases:22.48%
controls:18.70%
cases:9.40%
controls:7.03%
—
—
—
—
cases:1.38%
controls:1.11%
cases:11.45%
controls:6.35%
cases:23.81%
controls:16.57%
98
814
338
3538
41
306
395
4046
—
—
6
48
429
4294
49
270
379
3980
90
616
288
3102
Acute bronchitis, unspecified
J20.9 [45562445]
1.1e+00
—
—
—
—
9.2e-01
5.5e-01
cases:4.36%
controls:1.52%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.47%
cases:3.97%
controls:2.34%
19
66
417
4286
—
—
—
—
5
20
423
4230
15
87
363
3631
Stomach Pathology biopsy report
66114-0 [40768797]
1.8e-01
—
—
—
—
—
1.1e+00
cases:2.29%
controls:1.93%
—
—
—
—
—
—
—
—
—
—
cases:4.23%
controls:1.48%
10
84
426
4268
—
—
—
—
—
16
55
362
3663
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
5.5e-01
—
-1.0e+50
—
-1.0e+50
9.2e-01
1.1e+00
cases:3.21%
controls:1.88%
—
—
cases:0.00%
controls:0.11%
—
—
cases:0.00%
controls:0.12%
cases:1.40%
controls:0.56%
cases:6.61%
controls:2.37%
14
82
422
4270
—
0
5
436
4347
—
0
5
435
4337
6
24
422
4226
25
88
353
3630
ispaghula (psylla seeds); oral
A06AC01 [21600555]
3.4e-01
3.2e-01
—
—
—
5.2e-01
1.1e+00
cases:4.59%
controls:3.31%
cases:2.75%
controls:2.02%
—
—
—
—
—
—
cases:2.80%
controls:1.69%
cases:9.26%
controls:3.42%
20
144
416
4208
12
88
424
4264
—
—
—
12
72
416
4178
35
127
343
3591
Vascular Surgery
77 [38004496]
8.8e-01
—
-1.0e+50
—
—
1.1e+00
1.0e+00
cases:4.13%
controls:1.75%
—
—
cases:0.00%
controls:0.14%
—
—
—
—
cases:1.40%
controls:0.47%
cases:5.82%
controls:2.12%
18
76
418
4276
—
0
6
436
4346
—
—
6
20
422
4230
22
79
356
3639
Plastic And Reconstructive Surgery
24 [38004467]
1.4e-01
8.4e-01
—
—
—
—
1.0e+00
cases:3.21%
controls:2.80%
cases:1.83%
controls:0.80%
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.07%
14
122
422
4230
8
35
428
4317
—
—
—
—
21
77
357
3641
Asthma
J45 [45596282]
5.0e-01
1.4e+00
—
—
—
9.6e-01
1.0e+00
cases:2.98%
controls:1.84%
cases:2.29%
controls:0.60%
—
—
—
—
—
—
cases:1.40%
controls:0.54%
cases:4.50%
controls:1.67%
13
80
423
4272
10
26
426
4326
—
—
—
6
23
422
4227
17
62
361
3656
pH of Urine by Test strip
5803-2 [3022621]
5.1e-01
1.4e+00
—
—
—
1.2e+00
1.0e+00
cases:1.38%
controls:0.83%
cases:1.83%
controls:0.44%
—
—
—
—
—
—
cases:2.10%
controls:0.61%
cases:5.03%
controls:1.88%
6
36
430
4316
8
19
428
4333
—
—
—
9
26
419
4224
19
70
359
3648
Osmolality of Urine
2695-5 [3026782]
5.3e-01
6.4e-01
—
—
—
8.4e-01
1.0e+00
cases:4.82%
controls:2.90%
cases:2.06%
controls:1.10%
—
—
—
—
—
—
cases:2.57%
controls:1.13%
cases:7.67%
controls:2.93%
21
126
415
4226
9
48
427
4304
—
—
—
11
48
417
4202
29
109
349
3609
levocetirizine; oral
R06AE09 [21603498]
7.2e-01
1.0e+00
—
—
—
1.2e+00
1.0e+00
cases:3.44%
controls:1.70%
cases:2.06%
controls:0.74%
—
—
—
—
—
—
cases:2.34%
controls:0.68%
cases:4.50%
controls:1.69%
15
74
421
4278
9
32
427
4320
—
—
—
10
29
418
4221
17
63
361
3655
tamsulosin; oral
G04CA02 [21602669]
1.0e+00
5.6e-01
—
—
—
7.7e-01
2.3e-01
cases:3.67%
controls:1.38%
cases:1.83%
controls:1.06%
—
—
—
—
—
—
cases:2.10%
controls:0.99%
cases:3.17%
controls:2.53%
16
60
420
4292
8
46
428
4306
—
—
—
9
42
419
4208
12
94
366
3624
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
9.9e-01
3.9e-01
—
—
—
—
4.0e-01
cases:6.19%
controls:2.39%
cases:1.15%
controls:0.78%
—
—
—
—
—
—
—
—
cases:3.70%
controls:2.50%
27
104
409
4248
5
34
431
4318
—
—
—
—
14
93
364
3625
sulfadiazine and trimethoprim
J01EE02 [21602962]
3.9e-01
7.0e-01
—
—
-1.0e+50
—
9.9e-01
cases:2.75%
controls:1.88%
cases:1.15%
controls:0.57%
—
—
—
—
cases:0.00%
controls:0.12%
—
—
cases:5.03%
controls:1.94%
12
82
424
4270
5
25
431
4327
—
—
0
5
435
4337
—
19
72
359
3646
orphenadrine, combinations
M03BC51 [21604113]
9.8e-01
3.9e-01
—
—
—
—
2.9e-01
cases:5.73%
controls:2.23%
cases:1.15%
controls:0.78%
—
—
—
—
—
—
—
—
cases:3.17%
controls:2.39%
25
97
411
4255
5
34
431
4318
—
—
—
—
12
89
366
3629
Other specified special examinations
Z01.8 [45581003]
3.5e-01
—
-1.0e+50
—
—
1.0e+00
9.7e-01
cases:2.75%
controls:1.95%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.40%
controls:0.52%
cases:4.76%
controls:1.86%
12
85
424
4267
—
0
5
436
4347
—
—
6
22
422
4228
18
69
360
3649
Low back symptom/complaint
L03 [2002000628]
8.9e-01
1.3e+00
—
—
—
9.2e-01
9.6e-01
cases:3.67%
controls:1.54%
cases:2.29%
controls:0.67%
—
—
—
—
—
—
cases:1.87%
controls:0.75%
cases:6.61%
controls:2.64%
16
67
420
4285
10
29
426
4323
—
—
—
8
32
420
4218
25
98
353
3620
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
3.3e-01
—
—
—
—
1.3e+00
9.6e-01
cases:2.06%
controls:1.49%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.54%
cases:4.50%
controls:1.78%
9
65
427
4287
—
—
—
—
8
23
420
4227
17
66
361
3652
clarithromycin; oral, parenteral
J01FA09 [21602977]
7.4e-01
1.0e+00
—
—
—
—
9.5e-01
cases:5.73%
controls:2.83%
cases:2.29%
controls:0.83%
—
—
—
—
—
—
—
—
cases:5.29%
controls:2.12%
25
123
411
4229
10
36
426
4316
—
—
—
—
20
79
358
3639
temazepam; oral
N05CD07 [21604642]
9.3e-01
3.4e-01
—
—
1.5e+00
5.8e-01
7.0e-01
cases:5.50%
controls:2.25%
cases:1.83%
controls:1.31%
—
—
—
—
cases:1.15%
controls:0.25%
cases:2.34%
controls:1.32%
cases:4.76%
controls:2.42%
24
98
412
4254
8
57
428
4295
—
—
5
11
430
4331
10
56
418
4194
18
90
360
3628
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.0e-01
2.8e-01
—
—
—
3.0e-01
8.8e-01
cases:4.13%
controls:3.75%
cases:2.29%
controls:1.75%
—
—
—
—
—
—
cases:2.34%
controls:1.74%
cases:11.38%
controls:5.06%
18
163
418
4189
10
76
426
4276
—
—
—
10
74
418
4176
43
188
335
3530
Shoulder symptom/complaint
L08 [2002000632]
4.0e-01
—
—
—
—
—
8.7e-01
cases:2.52%
controls:1.70%
—
—
—
—
—
—
—
—
—
—
cases:6.08%
controls:2.64%
11
74
425
4278
—
—
—
—
—
23
98
355
3620
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
2.5e-01
7.0e-01
-1.0e+50
—
—
7.7e-01
8.7e-01
cases:2.52%
controls:1.98%
cases:1.83%
controls:0.92%
cases:0.00%
controls:0.16%
—
—
—
—
cases:2.10%
controls:0.99%
cases:7.67%
controls:3.36%
11
86
425
4266
8
40
428
4312
0
7
436
4345
—
—
9
42
419
4208
29
125
349
3593
Urinary tract infection, site not specified
N39.0 [45548665]
6.4e-01
—
—
—
—
—
8.7e-01
cases:1.61%
controls:0.85%
—
—
—
—
—
—
—
—
—
—
cases:5.29%
controls:2.29%
7
37
429
4315
—
—
—
—
—
20
85
358
3633
oxazepam; oral
N05BA04 [21604569]
3.8e-01
3.8e-01
—
—
—
3.7e-01
8.7e-01
cases:5.50%
controls:3.84%
cases:2.75%
controls:1.91%
—
—
—
—
—
—
cases:2.80%
controls:1.95%
cases:8.99%
controls:3.98%
24
167
412
4185
12
83
424
4269
—
—
—
12
83
416
4167
34
148
344
3570
ethylmorphine; oral
R05DA01 [21603397]
8.5e-01
5.1e-01
—
—
—
—
4.4e-01
cases:6.19%
controls:2.73%
cases:1.15%
controls:0.69%
—
—
—
—
—
—
—
—
cases:3.97%
controls:2.58%
27
119
409
4233
5
30
431
4322
—
—
—
—
15
96
363
3622
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
3.2e-01
—
-1.0e+50
—
—
9.2e-01
8.5e-01
cases:4.36%
controls:3.22%
—
—
cases:0.00%
controls:0.16%
—
—
—
—
cases:1.87%
controls:0.75%
cases:6.35%
controls:2.82%
19
140
417
4212
—
0
7
436
4345
—
—
8
32
420
4218
24
105
354
3613
zolpidem; oral
N05CF02 [21604655]
3.9e-02
3.2e-01
—
—
-1.0e+50
3.4e-01
8.5e-01
cases:2.98%
controls:2.87%
cases:2.29%
controls:1.68%
—
—
—
—
cases:0.00%
controls:0.28%
cases:2.10%
controls:1.51%
cases:6.35%
controls:2.82%
13
125
423
4227
10
73
426
4279
—
—
0
12
435
4330
9
64
419
4186
24
105
354
3613
salmeterol and fluticasone
R03AK06 [21603280]
8.5e-01
6.2e-01
—
—
—
8.3e-01
6.5e-01
cases:5.05%
controls:2.23%
cases:2.75%
controls:1.49%
—
—
—
—
—
—
cases:3.04%
controls:1.34%
cases:3.70%
controls:1.96%
22
97
414
4255
12
65
424
4287
—
—
—
13
57
415
4193
14
73
364
3645
clindamycin; oral, parenteral
J01FF01 [21602985]
6.1e-01
—
—
—
—
5.8e-01
8.4e-01
cases:4.59%
controls:2.55%
—
—
—
—
—
—
—
—
cases:1.87%
controls:1.06%
cases:6.88%
controls:3.09%
20
111
416
4241
—
—
—
—
8
45
420
4205
26
115
352
3603
Thorax X-ray examination
GD1AA [2001303617]
-4.4e-02
-2.4e-02
—
—
—
8.3e-01
8.4e-01
cases:5.73%
controls:5.97%
cases:2.06%
controls:2.11%
—
—
—
—
—
—
cases:4.44%
controls:1.98%
cases:14.02%
controls:6.59%
25
260
411
4092
9
92
427
4260
—
—
—
19
84
409
4166
53
245
325
3473
Coloscopy
UJF32 [2001305029]
6.2e-01
—
-1.0e+50
—
—
1.1e+00
8.2e-01
cases:4.82%
controls:2.64%
—
—
cases:0.00%
controls:0.23%
—
—
—
—
cases:1.87%
controls:0.66%
cases:6.61%
controls:3.01%
21
115
415
4237
—
0
10
436
4342
—
—
8
28
420
4222
25
112
353
3606
furosemide; oral, parenteral
C03CA01 [21601518]
4.5e-01
4.4e-01
8.4e-01
—
4.2e-01
5.3e-01
8.0e-01
cases:6.19%
controls:4.04%
cases:5.28%
controls:3.45%
cases:1.83%
controls:0.80%
—
—
cases:1.61%
controls:1.06%
cases:5.61%
controls:3.39%
cases:10.58%
controls:5.03%
27
176
409
4176
23
150
413
4202
8
35
428
4317
—
7
46
428
4296
24
144
404
4106
40
187
338
3531
Inpatient Visit
IP [9201]
4.6e-01
4.2e-01
—
1.0e+50
—
3.4e-01
7.9e-01
cases:8.94%
controls:5.81%
cases:3.21%
controls:2.14%
—
—
cases:2.98%
controls:0.00%
—
—
cases:3.27%
controls:2.35%
cases:10.58%
controls:5.11%
39
253
397
4099
14
93
422
4259
—
13
0
423
4352
—
14
100
414
4150
40
190
338
3528
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.9e-01
4.2e-01
—
—
—
4.7e-01
7.9e-01
cases:5.05%
controls:4.20%
cases:2.98%
controls:1.98%
—
—
—
—
—
—
cases:3.27%
controls:2.07%
cases:12.70%
controls:6.21%
22
183
414
4169
13
86
423
4266
—
—
—
14
88
414
4162
48
231
330
3487
Bacteria [Presence] in Urine
87829-8 [36304419]
-1.8e-01
1.1e-01
—
—
—
-1.5e-01
7.7e-01
cases:2.98%
controls:3.56%
cases:1.83%
controls:1.65%
—
—
—
—
—
—
cases:1.40%
controls:1.62%
cases:9.52%
controls:4.63%
13
155
423
4197
8
72
428
4280
—
—
—
6
69
422
4181
36
172
342
3546
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
7.7e-01
5.8e-01
—
—
-1.0e+50
4.2e-01
6.5e-01
cases:5.96%
controls:2.85%
cases:1.83%
controls:1.03%
—
—
—
—
cases:0.00%
controls:0.18%
cases:1.64%
controls:1.08%
cases:5.82%
controls:3.12%
26
124
410
4228
8
45
428
4307
—
—
0
8
435
4334
7
46
421
4204
22
116
356
3602
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.3e-01
2.1e-01
1.8e-01
-1.0e+50
1.8e-01
1.7e-01
7.7e-01
cases:8.49%
controls:7.56%
cases:7.11%
controls:5.86%
cases:1.38%
controls:1.15%
cases:0.00%
controls:0.11%
cases:1.38%
controls:1.15%
cases:7.01%
controls:6.00%
cases:19.05%
controls:9.82%
37
329
399
4023
31
255
405
4097
6
50
430
4302
0
5
436
4347
6
50
429
4292
30
255
398
3995
72
365
306
3353
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
3.0e-01
5.2e-01
—
—
-1.0e+50
6.2e-01
7.5e-01
cases:5.50%
controls:4.14%
cases:2.52%
controls:1.52%
—
—
—
—
cases:0.00%
controls:0.39%
cases:2.80%
controls:1.53%
cases:10.32%
controls:5.16%
24
180
412
4172
11
66
425
4286
—
—
0
17
435
4325
12
65
416
4185
39
192
339
3526
Sleep apnoea
G47.3 [45562094]
5.9e-01
8.7e-01
—
—
1.1e+00
8.3e-01
7.5e-01
cases:5.05%
controls:2.87%
cases:4.13%
controls:1.77%
—
—
—
—
cases:1.15%
controls:0.39%
cases:4.44%
controls:1.98%
cases:7.41%
controls:3.66%
22
125
414
4227
18
77
418
4275
—
—
5
17
430
4325
19
84
409
4166
28
136
350
3582
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.7e-01
1.8e-02
—
—
—
-1.1e-01
7.3e-01
cases:10.55%
controls:8.27%
cases:4.82%
controls:4.73%
—
—
—
—
—
—
cases:4.21%
controls:4.66%
cases:17.72%
controls:9.39%
46
360
390
3992
21
206
415
4146
—
—
—
18
198
410
4052
67
349
311
3369
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.9e-01
-1.9e-03
—
—
—
-6.6e-02
7.2e-01
cases:9.63%
controls:8.09%
cases:4.59%
controls:4.60%
—
—
—
—
—
—
cases:4.44%
controls:4.73%
cases:17.20%
controls:9.20%
42
352
394
4000
20
200
416
4152
—
—
—
19
201
409
4049
65
342
313
3376
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
5.3e-01
3.6e-01
—
—
1.4e+00
6.6e-01
7.2e-01
cases:9.40%
controls:5.77%
cases:3.21%
controls:2.25%
—
—
—
—
cases:1.15%
controls:0.28%
cases:3.97%
controls:2.09%
cases:11.64%
controls:6.05%
41
251
395
4101
14
98
422
4254
—
—
5
12
430
4330
17
89
411
4161
44
225
334
3493
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.8e-01
-1.9e-03
—
—
—
-6.6e-02
7.1e-01
cases:9.63%
controls:8.16%
cases:4.59%
controls:4.60%
—
—
—
—
—
—
cases:4.44%
controls:4.73%
cases:17.20%
controls:9.23%
42
355
394
3997
20
200
416
4152
—
—
—
19
201
409
4049
65
343
313
3375
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.0e-01
-1.2e-02
—
—
—
-7.2e-02
7.1e-01
cases:9.63%
controls:8.04%
cases:4.59%
controls:4.64%
—
—
—
—
—
—
cases:4.44%
controls:4.75%
cases:17.20%
controls:9.23%
42
350
394
4002
20
202
416
4150
—
—
—
19
202
409
4048
65
343
313
3375
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
7.1e-01
6.1e-01
—
—
—
2.3e-01
3.9e-01
cases:6.88%
controls:3.49%
cases:3.44%
controls:1.91%
—
—
—
—
—
—
cases:2.34%
controls:1.86%
cases:6.88%
controls:4.76%
30
152
406
4200
15
83
421
4269
—
—
—
10
79
418
4171
26
177
352
3541
Telephone prescription or other care instructions
WZB00 [2001310884]
-2.1e-02
—
—
—
—
7.0e-01
7.1e-01
cases:3.67%
controls:3.75%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.94%
cases:7.67%
controls:3.93%
16
163
420
4189
—
—
—
—
8
40
420
4210
29
146
349
3572
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.8e-01
2.4e-01
—
—
—
4.2e-01
7.1e-01
cases:5.73%
controls:4.85%
cases:3.21%
controls:2.55%
—
—
—
—
—
—
cases:3.97%
controls:2.64%
cases:14.55%
controls:7.75%
25
211
411
4141
14
111
422
4241
—
—
—
17
112
411
4138
55
288
323
3430

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
66
176
4.23
22.71
3.8
3.6
1.02
1.02
ratio
0.44
61
168
124
526
2.88
20.41
3.2
2.6
3.80
3.32
e6/l
0.13
72
249
127
567
2.74
18.80
3.3
2.5
0.79
1.25
e6/l
1.37
73
289
197
1092
2.44
18.46
3.6
2.7
0.00
0.00
-0.00
13
19
138
697
2.42
15.41
1.5
1.3
15.13
33.47
iu/ml
3.60
50
234
149
795
2.31
14.55
1.8
1.6
1.43
1.25
mg/l
0.11
118
626
166
963
2.15
12.93
3.4
2.8
0.24
0.46
e6/l
1.46
116
697
186
1131
2.11
12.78
3.6
2.9
14.54
111.85
e6/l
1.02
137
861
280
1985
2.11
12.66
4.3
3.4
0.00
0.00
estimate
0.50
54
402
208
1331
2.06
12.34
4.2
3.4
49.31
132.39
e6/l
1.69
140
910
280
2006
2.07
12.04
4.4
3.4
0.00
0.00
estimate
-0.00
58
408
281
2021
2.06
11.89
4.5
3.4
0.15
0.02
estimate
0.64
54
377
276
1982
2.03
11.60
5.6
6.4
0.18
0.18
e9/l
0.02
237
1742
268
1920
2.00
11.16
5.2
6.1
0.04
0.04
e9/l
0.12
220
1662
389
3218
2.66
11.11
23.1
17.3
13.66
13.61
%
0.33
389
3178
74
322
2.56
11.09
4.1
2.7
3.13
1.78
mmol/l
1.86
62
284
76
335
2.53
11.09
4.1
2.7
7.39
7.38
ph
0.33
50
201
267
1917
1.98
10.97
5.2
6.1
0.59
0.57
e9/l
0.32
218
1659
246
1719
1.96
10.93
10.5
10.7
0.00
0.00
e9/l
0.09
193
1421
270
1953
1.97
10.77
5.4
6.1
1.83
1.94
e9/l
0.76
231
1734
34
96
3.75
10.69
4.7
4.4
—
—
—
0
0
358
2883
2.24
10.41
8.1
7.7
79.47
78.66
u/l
0.10
341
2733
118
647
2.12
10.29
1.5
1.3
11.70
17.14
u/ml
0.41
57
251
87
431
2.27
9.72
2.4
2.4
6.25
8.54
umol/l
0.83
80
376
246
1768
1.88
9.54
5.4
6.2
0.69
0.72
%
0.39
229
1658
379
3176
2.30
9.16
25.0
17.9
331.45
331.96
g/l
0.55
379
3159
245
1775
1.85
9.10
5.5
6.2
8.79
8.83
%
0.07
228
1676
225
1590
1.84
9.04
4.2
4.6
35.73
35.72
g/l
0.01
219
1509
244
1770
1.84
8.98
5.3
6.1
2.83
2.77
%
0.17
227
1669
63
282
2.44
8.83
3.6
2.3
5.96
6.08
ph
0.55
52
187
248
1815
1.83
8.80
5.5
6.1
27.48
27.84
%
0.21
231
1737
281
2138
1.85
8.77
5.4
4.3
6.52
6.73
mmol/l
0.91
266
2032
246
1798
1.82
8.75
5.5
6.0
57.42
57.36
%
0.03
233
1726
236
1704
1.82
8.73
2.5
2.7
—
—
estimate
—
0
0
249
1836
1.81
8.51
6.7
6.5
1.22
1.22
mmol/l
0.23
228
1587
89
469
2.12
8.46
7.1
6.3
104.19
104.25
mmol/l
0.04
89
469
69
329
2.30
8.38
2.4
2.0
30.22
37.13
u/l
0.78
59
279
116
677
1.96
8.33
3.1
2.7
541.78
528.78
mosm/kgh2o
0.22
98
599
98
541
2.04
8.22
1.5
1.3
305.00
519.70
titre
2.20
16
133
279
2154
1.79
7.92
8.5
10.3
4.21
4.06
e9/l
0.42
229
1876
111
659
1.91
7.50
2.8
3.5
128.99
393.16
ng/l
1.23
82
497
58
269
2.33
7.50
6.1
7.2
—
—
—
0
0
33
116
2.99
7.39
1.1
1.1
—
—
—
0
0
168
1139
1.76
7.35
6.2
6.2
—
—
—
0
0
141
910
1.80
7.28
2.5
2.5
326.86
333.22
umol/l
0.34
120
816
216
1577
1.72
7.22
3.8
3.1
6.29
6.21
ph
0.55
127
921
418
3748
2.90
7.21
19.6
13.3
20.76
24.08
mg/l
1.27
370
3029
255
1963
1.70
6.89
6.0
6.6
10.60
11.51
umol/l
0.99
243
1882
406
3607
2.43
6.85
6.0
5.3
1.82
1.91
mu/l
0.98
389
3338
358
3058
1.87
6.43
4.6
4.4
14.84
14.75
pmol/l
0.27
340
2815
163
1130
1.70
6.40
3.3
2.8
—
—
—
0
0
206
1521
1.66
6.35
4.4
3.4
0.07
0.04
estimate
0.23
44
334
159
1110
1.67
6.01
3.7
3.5
7.39
7.40
ph
0.44
115
768
42
187
2.38
5.95
3.2
2.2
1.16
1.21
%
0.14
42
187
185
1349
1.64
5.86
4.9
3.5
22.21
39.68
ng/l
1.74
125
946
27
97
2.90
5.84
1.3
1.1
—
—
—
0
0
171
1226
1.64
5.78
5.0
5.9
—
—
—
0
0
126
835
1.71
5.74
4.5
3.5
1.02
1.02
kg/l
0.05
87
560
411
3726
2.35
5.65
5.5
4.9
5.98
5.92
mmol/l
0.40
395
3431
320
2687
1.68
5.61
4.6
3.7
—
0.17
—
0
6
88
530
1.82
5.56
1.7
1.7
31.25
29.00
s
2.71
88
516
61
327
2.00
5.46
2.1
2.0
0.00
0.07
estimate
0.78
12
67
77
451
1.86
5.31
2.4
2.3
150.44
99.21
ug/g
0.42
64
362
51
262
2.07
5.13
1.1
1.4
89.26
193.70
u/ml
1.83
46
244
38
174
2.29
5.07
1.9
1.8
—
—
—
0
0
176
1306
1.58
4.99
2.9
3.2
33.87
33.72
u/l
0.01
170
1240
422
3914
2.51
4.71
15.7
12.6
—
—
—
0
0
208
1619
1.53
4.68
7.1
5.6
1.22
1.22
mmol/l
0.08
197
1507
213
1675
1.52
4.52
16.2
12.6
1.23
1.21
inr
0.13
173
1379
154
1132
1.55
4.45
3.6
3.0
0.04
0.01
estimate
0.55
47
320
35
164
2.23
4.44
2.9
2.6
—
—
—
0
0
46
242
2.00
4.35
2.4
2.4
17.25
26.28
au/ml
—
6
24
145
1060
1.55
4.26
3.3
3.2
1136.42
1127.24
ng/l
0.01
128
903
18
62
2.98
4.22
1.4
1.3
—
—
—
0
0
76
476
1.72
4.16
1.5
1.3
—
—
—
0
0
221
1789
1.47
3.87
3.6
2.9
92.29
118.36
ug/l
2.68
214
1673
79
510
1.67
3.86
2.1
1.9
—
—
—
0
0
22
90
2.52
3.78
1.6
1.4
1634.17
23710.86
e6/l
2.05
12
64
153
1157
1.49
3.76
2.7
2.3
59.13
61.39
u/l
0.15
144
1076
155
1185
1.47
3.57
2.1
2.3
—
—
—
0
0
216
1762
1.44
3.52
2.5
2.4
75.77
78.07
nmol/l
0.56
200
1600
14
47
3.04
3.44
2.3
2.2
1.21
1.19
mmol/l
0.79
14
47
14
47
3.04
3.44
2.3
2.2
4.12
3.94
mmol/l
0.74
14
47
14
47
3.04
3.44
2.3
2.2
106.21
105.47
mmol/l
0.23
14
47
307
2682
1.47
3.41
2.8
2.9
54.78
47.89
u/l
0.31
292
2537
35
184
1.98
3.35
1.3
1.1
—
—
—
0
0
428
4062
2.40
3.31
13.4
11.0
26.01
25.39
u/l
0.40
420
3939
74
492
1.60
3.22
1.2
1.2
—
—
—
0
0
124
930
1.46
3.09
4.0
4.2
—
—
—
0
0
107
780
1.49
3.07
2.7
2.5
4.04
6.82
e6/l
1.54
93
718
41
235
1.82
3.05
1.8
3.2
137.34
196.17
ng/l
0.68
35
213
12
36
3.40
3.04
1.4
1.3
—
—
nmol/l
—
0
0
66
433
1.62
3.03
1.5
1.3
—
—
—
0
0
193
1579
1.39
2.94
2.6
2.1
—
—
—
0
0
61
398
1.62
2.86
2.1
1.5
—
—
—
0
0
165
1320
1.40
2.85
3.2
3.4
2.36
2.36
mmol/l
0.29
157
1217
83
583
1.52
2.84
2.5
2.2
12.00
12.88
umol/l
0.57
78
541
53
335
1.66
2.82
3.6
4.7
0.56
0.12
%
—
8
85
116
883
1.42
2.63
1.4
1.3
0.74
1.71
u/ml
1.17
30
243
21
100
2.15
2.63
1.3
1.4
265.33
272.80
ug/g
—
9
62
390
3641
1.58
2.58
7.6
6.0
39.38
39.07
mmol/mol
0.31
371
3416
5
7
7.21
2.55
5.2
5.7
0.39
0.35
umol/l
—
5
7
16
69
2.37
2.51
1.4
1.5
—
—
—
0
0
15
64
2.39
2.41
1.8
1.8
—
—
—
0
0
22
111
2.03
2.40
2.1
2.7
—
—
—
0
0
14
58
2.46
2.39
1.1
1.1
—
—
—
0
0
134
1065
1.37
2.34
1.4
1.4
—
—
—
0
0
161
1317
1.35
2.33
4.4
3.2
—
0.80
—
0
5
18
85
2.16
2.32
1.8
1.8
5.15
93.61
e6/l
1.59
13
61
433
4179
2.34
2.32
28.8
21.1
259.29
254.07
e9/l
0.93
428
4080
115
894
1.39
2.29
4.9
4.8
—
—
—
0
0
11
40
2.79
2.29
2.1
1.9
—
—
—
0
0
433
4182
2.31
2.26
28.8
21.1
4.47
4.49
e12/l
0.37
428
4068
433
4183
2.30
2.24
28.8
21.1
7.17
6.62
e9/l
0.62
428
4068
53
357
1.55
2.20
3.7
4.6
1.63
0.98
%
—
8
106
101
773
1.40
2.20
1.5
1.5
2.35
2.40
g/l
0.11
67
491
35
213
1.70
2.17
9.9
8.7
0.57
0.64
%
0.63
35
213
25
138
1.86
2.14
1.4
1.3
—
—
—
0
0
57
394
1.51
2.11
8.4
7.2
11.86
12.58
kpa
0.61
51
389
39
247
1.63
2.09
2.5
2.4
11.11
6.78
ug/l
0.37
34
224
57
396
1.50
2.07
8.4
7.1
0.99
1.26
mmol/l
0.18
47
336
36
225
1.65
2.04
2.0
1.7
—
—
—
0
0
44
290
1.57
2.02
2.5
3.0
1.22
1.23
mmol/l
0.65
38
246
43
282
1.58
2.01
3.2
3.1
95.06
77.28
ng/l
0.80
37
253
115
912
1.35
2.01
2.5
2.1
2.77
2.95
mg/l
0.33
103
772
20
105
1.95
1.99
13.9
6.8
—
—
—
0
0
190
1621
1.30
1.98
2.4
2.0
94.18
97.22
pmol/l
0.47
104
823
94
725
1.38
1.95
2.6
2.9
2.46
2.46
mmol/l
0.03
82
665
17
85
2.04
1.93
1.6
1.7
86.73
4.68
e6/l
0.50
11
59
24
136
1.81
1.91
2.0
1.6
11.79
15.05
u/ml
—
8
34
410
3919
1.59
1.88
6.0
5.6
2.85
2.79
mmol/l
0.59
393
3645
19
100
1.94
1.88
2.4
2.0
643.63
273.87
ug/l
0.41
19
93
19
100
1.94
1.88
1.1
1.2
—
—
—
0
0
16
79
2.06
1.87
1.5
1.8
—
—
—
0
0
56
397
1.47
1.85
8.5
7.2
7.42
7.42
ph
0.01
21
240
54
381
1.47
1.83
1.5
1.4
—
—
—
0
0
9
35
2.60
1.81
1.0
1.1
—
—
—
0
0
14
67
2.12
1.78
1.1
1.6
0.40
0.32
nmol/l
—
9
49
388
3679
1.43
1.73
4.4
4.2
1.40
1.27
mmol/l
2.59
372
3384
49
343
1.48
1.73
3.3
4.7
1.00
0.72
%
—
6
102
12
56
2.17
1.62
1.3
1.0
33.80
14.70
au/ml
—
5
21
70
532
1.37
1.60
1.4
1.6
—
—
—
0
0
5
15
3.36
1.52
2.0
1.8
—
—
—
0
0
35
236
1.52
1.49
4.2
3.1
—
—
—
0
0
10
45
2.25
1.47
1.3
1.1
—
—
—
0
0
48
347
1.43
1.46
4.1
5.0
0.00
0.23
%
—
6
83
99
806
1.29
1.42
4.5
4.8
1.34
2.12
ug/l
2.36
88
738
54
402
1.39
1.41
1.5
1.5
—
—
—
0
0
7
29
2.44
1.39
1.6
1.0
29.86
34.28
mg/l
—
7
23
13
67
1.97
1.39
1.5
1.6
51.46
60.95
%
0.77
13
67
78
617
1.32
1.38
1.8
1.8
—
—
—
0
0
22
344
0.62
1.38
1.3
1.9
3.69
3.47
mmol/l
0.39
13
252
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
9
43
2.12
1.31
1.6
1.9
—
—
—
0
0
6
24
2.52
1.31
1.0
1.0
—
—
—
0
0
402
3872
1.40
1.28
5.2
4.9
4.80
4.76
mmol/l
0.27
386
3614
53
401
1.37
1.27
2.2
3.1
1.70
1.86
%
0.79
48
366
16
92
1.77
1.26
1.1
1.3
—
—
—
0
0
32
223
1.47
1.20
2.2
2.3
—
—
—
0
0
36
257
1.44
1.20
1.2
1.3
—
—
—
0
0
400
3860
1.36
1.15
5.1
4.8
1.45
1.52
mmol/l
3.04
382
3581
0
36
0.00
1.14
0.0
16.2
—
908.67
—
0
36
8
41
1.97
1.09
1.0
1.1
—
—
—
0
0
7
32
2.21
1.08
1.1
1.5
8.23
10.98
%
—
7
32
14
82
1.73
1.06
4.4
3.8
22.36
35.24
mg/l
—
8
57
146
1284
1.20
1.05
3.2
3.2
7.94
7.44
mmol/l
0.57
124
1101
60
479
1.29
1.02
2.7
2.9
0.62
0.73
ug/l
0.64
32
291
40
302
1.36
1.00
1.3
1.2
—
—
—
0
0
11
181
0.60
0.90
1.5
2.0
0.00
0.02
estimate
—
6
55
36
274
1.34
0.87
1.4
1.4
—
—
—
0
0
6
31
1.95
0.84
1.2
1.3
17.30
23.67
ng/l
—
6
31
8
45
1.79
0.84
1.5
2.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
11
66
1.68
0.79
1.4
1.1
3.33
3.85
u/ml
—
6
27
12
74
1.64
0.79
2.0
1.5
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
50
406
1.26
0.77
1.4
1.5
—
—
—
0
0
9
55
1.65
0.74
1.1
1.2
—
—
—
0
0
37
291
1.30
0.74
1.1
1.2
98.52
145.70
u/ml
0.32
12
115
11
69
1.61
0.69
1.2
1.7
5.27
4.96
mmol/24h
0.10
11
58
10
154
0.64
0.65
2.7
3.8
—
—
—
0
0
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
68
584
1.19
0.64
1.7
1.7
1089.62
1124.53
nmol/l
0.13
58
443
5
30
1.67
0.61
1.0
1.2
95.60
104.30
pmol/l
—
5
30
134
1220
1.14
0.61
3.6
3.3
28.70
45.28
mg/l
1.04
85
757
119
1077
1.14
0.59
4.3
3.5
0.00
0.01
estimate
0.99
48
390
21
158
1.35
0.58
1.4
1.6
0.20
0.32
mg/l
—
10
72
6
35
1.72
0.58
1.0
1.4
3.04
2.91
g/l
—
6
23
6
35
1.72
0.58
1.0
1.4
6.20
7.76
g/l
—
6
23
6
35
1.72
0.58
1.0
1.4
0.41
0.39
g/l
—
6
23
30
239
1.27
0.57
3.0
2.4
14.56
13.10
nmol/l
0.49
30
227
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
23
178
1.31
0.54
2.0
2.0
3.64
7.46
iu/ml
—
8
39
11
74
1.50
0.54
3.2
1.7
232.27
220.62
pmol/l
0.18
11
69
117
1065
1.13
0.53
1.6
1.6
19.88
20.46
nmol/l
0.17
103
888
9
62
1.46
0.53
1.2
1.2
—
—
—
0
0
6
39
1.55
0.53
1.0
1.6
2.53
4.92
umol/l
—
6
26
6
40
1.51
0.52
1.2
1.5
—
—
—
0
0
136
1254
1.12
0.50
4.5
4.0
3.78
7.67
mg/mmol
1.75
82
758
12
84
1.44
0.49
1.0
1.1
—
—
—
0
0
12
84
1.44
0.49
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
48
417
1.17
0.43
3.0
5.0
3.36
19.09
ug/l
0.87
37
336
8
56
1.44
0.42
2.0
2.3
5.03
3.98
e9/l
—
8
56
5
34
1.48
0.40
2.8
3.7
1.42
162.27
nmol/l
—
5
34
5
34
1.48
0.40
1.2
1.3
314.40
274.63
mu/l
—
5
27
59
524
1.15
0.40
1.3
1.3
—
—
—
0
0
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
21
169
1.25
0.39
1.3
1.2
—
—
—
0
0
16
203
0.78
0.38
10.7
4.9
—
—
—
0
0
9
70
1.29
0.37
1.3
3.2
—
—
—
0
0
6
43
1.40
0.35
2.7
2.9
—
—
—
0
0
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
26
304
0.85
0.31
2.0
3.2
—
—
—
0
0
8
106
0.75
0.29
1.0
1.2
—
102.73
—
0
11
7
57
1.23
0.29
1.3
1.6
—
—
—
0
0
8
62
1.30
0.28
1.0
2.3
0.41
1.05
g/l
—
8
48
14
113
1.25
0.27
1.6
2.0
2.60
4.94
iu/l
—
5
49
13
104
1.26
0.26
1.2
1.3
—
—
—
0
0
5
75
0.66
0.26
1.2
1.2
6.64
41.32
u/l
—
5
65
10
78
1.29
0.24
2.0
2.2
60.59
58.33
%
—
10
78
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
0.12
—
0
6
28
249
1.13
0.21
2.6
2.2
41.32
106.78
u/ml
0.66
28
241
0
13
0.00
0.21
0.0
2.5
—
130265.88
—
0
8
7
59
1.19
0.18
1.4
1.7
—
—
—
0
0
24
214
1.13
0.18
1.1
1.1
—
—
—
0
0
5
66
0.75
0.17
1.8
1.6
—
—
—
0
0
38
353
1.08
0.14
1.4
1.5
—
—
—
0
0
33
307
1.08
0.12
2.0
3.6
68.30
72.50
e9/l
0.28
23
227
173
1692
1.04
0.12
1.7
1.8
1.50
1.35
mmol/l
0.83
154
1432
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
6
54
1.11
0.09
1.3
2.7
33.83
32.22
pg
—
6
54
5
60
0.83
0.08
1.0
1.3
47.80
56.15
mmol/l
—
5
52
13
117
1.11
0.08
1.2
1.3
—
—
—
0
0
13
117
1.11
0.08
1.2
1.3
—
—
—
0
0
13
117
1.11
0.08
1.2
1.3
—
—
—
0
0
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
170
1673
1.03
0.08
3.4
3.2
—
—
—
0
0
16
147
1.09
0.07
1.2
1.2
1.53
1.60
g/l
0.40
16
147
13
119
1.10
0.06
1.2
1.3
—
—
—
0
0
16
149
1.08
0.05
1.2
1.2
0.96
0.92
g/l
0.22
16
149
80
793
1.01
0.01
1.5
1.7
397.06
41141581.92
pmol/l
1.18
71
666
11
105
1.05
0.00
4.5
3.2
28.46
57.25
mg/l
0.50
11
87
11
105
1.05
0.00
4.5
3.2
52.45
53.50
mg/l
0.02
11
87
10
98
1.02
0.00
12.0
4.1
3.82
3.87
mmol/l
—
10
98
29
293
0.99
0.00
1.8
1.7
—
—
—
0
0
13
131
0.99
0.00
1.2
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
7
76
0.92
0.00
1.3
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
1.78
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
3.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
0.02
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
483.00
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
6.90
—
0
8
0
8
0.00
-0.00
0.0
2.1
—
2.00
—
0
8
5
56
0.89
-0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
18.48
—
0
8
0
8
0.00
-0.00
0.0
2.9
—
2657.38
—
0
8

Mortality – FinRegistry

↥

Association

Association between endpoint M13_TIBIALCOLLATERAL and mortality.

Females

Parameter HR [95% CI] p-value
M13_TIBIALCOLLATERAL 0.731 [0.58, 0.92] 0.008
Birth year 0.995 [0.99, 1.0] 0.297

During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 1195 females with M13_TIBIALCOLLATERAL died.

Males

Parameter HR [95% CI] p-value
M13_TIBIALCOLLATERAL 1.153 [0.89, 1.5] 0.286
Birth year 0.989 [0.98, 1.0] 0.031

During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 529 males with M13_TIBIALCOLLATERAL died.

Mortality risk

Mortality risk for people of age

years, who have M13_TIBIALCOLLATERAL.

N-year risk Females Males
1 0.061% 0.217%
5 0.427% 1.509%
10 1.123% 3.654%
15 2.112% 6.848%
20 3.733% 12.032%

Relationships between endpoints

↥

Index endpoint: M13_TIBIALCOLLATERAL – Tibial collateral bursitis [Pellegrini-Stieda]

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data